AGREEMENT AND PLAN OF MERGER AND REORGANIZATION

                                     BETWEEN

                             RF MICRO DEVICES, INC.,

                                       AND

                          RESONEXT COMMUNICATIONS, INC.

                          DATED AS OF OCTOBER 15, 2002






                                TABLE OF CONTENTS

                                                                                                               PAGE
        

Section 1  Description of Transaction.............................................................................1
   1.1            Merger of Company into and with Acquiror........................................................1
   1.2            Effect of the Merger............................................................................1
   1.3            Closing; Effective Time.........................................................................2
   1.4            Articles of Incorporation and Bylaws; Directors and Officers....................................2
   1.5            Conversion of Shares............................................................................2
   1.6            Closing of the Company's Transfer Books.........................................................5
   1.7            Exchange of Certificates........................................................................5
   1.8            Stockholders' Representative....................................................................6
   1.9            Tax Consequences................................................................................8
   1.10           Certain Payments................................................................................8
   1.11           Structure.......................................................................................8
   1.12           Further Action..................................................................................9
   1.13           Lock-Up.........................................................................................9
Section 2  Representations and Warranties of the Company.........................................................10
   2.1            Due Organization, Subsidiaries, etc............................................................10
   2.2            Certificate of Incorporation and Bylaws; Corporate Records.....................................11
   2.3            Capitalization, etc............................................................................11
   2.4            Authorization of Transaction...................................................................13
   2.5            Financial Statements...........................................................................14
   2.6            Absence of Changes.............................................................................14
   2.7            Title to and Sufficiency of Assets.............................................................16
   2.8            Product Warranties.............................................................................16
   2.9            Proprietary Assets.............................................................................16
   2.10           Contracts......................................................................................18
   2.11           Compliance with Legal Requirements.............................................................18
   2.12           Governmental Authorizations....................................................................18
   2.13           Tax Matters....................................................................................19
   2.14           Employee and Labor Matters; Benefit Plans......................................................20
   2.15           Environmental Matters..........................................................................23
   2.16           Legal Proceedings; Orders......................................................................23
   2.17           Real Property..................................................................................24
   2.18           Insurance......................................................................................24
   2.19           Inapplicability of Anti-Takeover Statutes; Dissenters' Rights..................................24
   2.20           Non-Contravention; Consents....................................................................24
   2.21           Names..........................................................................................25
   2.22           Bank Account...................................................................................25
   2.23           Full Disclosure................................................................................26
   2.24           Affiliate Transactions.........................................................................26
   2.25           Officer and Director Liability.................................................................26
Section 3  Representations and Warranties of Acquiror............................................................26
   3.1            Due Organization; Subsidiaries; etc............................................................26
   3.2            Articles of Incorporation and Bylaws...........................................................26
   3.3            Capitalization.................................................................................26
   3.4            SEC Filings; Financial Statements..............................................................27
   3.5            Absence of Certain Changes.....................................................................27
   3.6            Absence of Undisclosed Liabilities.............................................................28
   3.7            Litigation.....................................................................................28
   3.8            Authority; Binding Nature of Agreement.........................................................28
   3.9            Non-Contravention; Consents....................................................................28
   3.10           Full Disclosure................................................................................29
   3.11           Valid Issuance.................................................................................29
Section 4  Certain Covenants of the Company and Acquiror.........................................................29
   4.1            Access and Investigation.......................................................................29
   4.2            Operation of the Company's Business............................................................29
   4.3            Operation of Acquiror's Business...............................................................32
   4.4            No Solicitation................................................................................33
Section 5  Additional Covenants of the Parties...................................................................33
   5.1            Action by Certain Company Stockholders.........................................................33
   5.2            Regulatory Approvals...........................................................................33
   5.3            Stock Options..................................................................................33
   5.4            Employee Benefits..............................................................................34
   5.5            Additional Agreements..........................................................................35
   5.6            Disclosure.....................................................................................36
   5.7            Tax Representation Letters.....................................................................36
   5.8            Termination of Agreements......................................................................36
   5.9            Registration Exemption; Fairness Hearing.......................................................37
   5.10           Company Stockholders' Meeting..................................................................39
   5.11           Affiliate Agreements...........................................................................40
   5.12           Letter of the Company's Accountants............................................................40
   5.13           Confidentiality................................................................................40
   5.14           Tax-Free Reorganization........................................................................40
   5.15           No Undue Delay.................................................................................40
   5.16           Directors and Officers Protection..............................................................40
Section 6  Conditions Precedent to Obligations of Acquiror.......................................................41
   6.1            Accuracy of Representations....................................................................41
   6.2            Performance of Covenants.......................................................................41
   6.3            Stockholder Approval...........................................................................41
   6.4            Consents.......................................................................................41
   6.5            Agreements and Documents.......................................................................41
   6.6            No Material Adverse Effect.....................................................................42
   6.7            HSR Act........................................................................................42
   6.8            No Restraints..................................................................................42
   6.9            No Governmental Litigation.....................................................................42
   6.10           Cash Balance...................................................................................42
   6.11           Payment of Expenses............................................................................43
Section 7  Conditions Precedent to Obligation of the Company.....................................................43
   7.1            Accuracy of Representations....................................................................43
   7.2            Performance of Covenants.......................................................................43
   7.3            Documents......................................................................................43
   7.4            HSR Act........................................................................................43
   7.5            No Restraints..................................................................................43
   7.6            No Material Adverse Effect.....................................................................43
   7.7            Permit Application Approved; Registration Statement Effective;
                       Proxy Statement...........................................................................44
   7.8            Exchange Listing...............................................................................44
Section 8  Indemnification.......................................................................................44
   8.1            Indemnification by Stockholders................................................................44
   8.2            Indemnification by the Company.................................................................44
   8.3            Indemnification by Acquiror....................................................................44
   8.4            Notice of Claim................................................................................45
   8.5            Defense........................................................................................45
   8.6            Other Remedies.................................................................................45
   8.7            Maximum Indemnity Amount.......................................................................45
   8.8            Time Limitations...............................................................................46
   8.9            Waiver of Conditions...........................................................................46
Section 9  Termination...........................................................................................46
   9.1            Termination....................................................................................46
   9.2            Effect of Termination..........................................................................47
   9.3            Expenses.......................................................................................47
Section 10  Miscellaneous Provisions.............................................................................47
   10.1           Amendment......................................................................................47
   10.2           Waiver.........................................................................................48
   10.3           Survival of Representations and Warranties.....................................................48
   10.4           Entire Agreement; Counterparts.................................................................48
   10.5           Applicable Law; Jurisdiction...................................................................48
   10.6           Attorneys' Fees................................................................................49
   10.7           Assignability..................................................................................49
   10.8           Notices........................................................................................49
   10.9           Cooperation....................................................................................50
   10.10          Construction...................................................................................50



EXHIBITS:

Exhibit A:        Certain Definitions
Exhibit B:        Escrow Agreement
Exhibit C:        Company Disclosure Schedule
Exhibit D:        Acquiror Disclosure Schedule
Exhibit E:        Affiliate Agreement






                 AGREEMENT AND PLAN OF MERGER AND REORGANIZATION

         THIS AGREEMENT AND PLAN OF MERGER AND REORGANIZATION (this "Agreement")
is made and entered into as of October 15, 2002, by and among RF MICRO  DEVICES,
INC., a North Carolina corporation  ("Acquiror"),  and RESONEXT  COMMUNICATIONS,
INC., a Delaware corporation (the "Company").  Certain capitalized terms used in
this Agreement are defined in Exhibit A.

                                    RECITALS

         A. Acquiror and the Company intend to effect a merger (the "Merger") of
the  Company  into and with  Acquiror in  accordance  with this  Agreement,  the
Delaware  General  Corporation  Law  ("DGCL")  and the North  Carolina  Business
Corporation Act ("NCBCA").

         B. It is intended that the Merger qualify as a tax-free  reorganization
within the meaning of Section  368(a) of the Internal  Revenue Code of 1986,  as
amended (the "Code").

         C. The respective  boards of directors of Acquiror and the Company have
approved this Agreement and approved the Merger.

         D. In order to  induce  Acquiror  to enter  into  this  Agreement,  (i)
certain  stockholders  listed in Part 5.1(a) of the Company Disclosure  Schedule
have entered into Proxy and Voting  Agreements with Acquiror,  pursuant to which
such  individuals  have agreed to certain  matters with respect to the voting of
certain shares of Company Common Stock and Company Preferred Stock in connection
with the Merger and (ii) the  individuals  listed in Part  5.1(b) of the Company
Disclosure  Schedule  have  entered  into  certain  Employment  Agreements  with
Acquiror that will become effective  concurrent with (and conditioned  upon) the
Merger.

                                    AGREEMENT

         The parties to this Agreement,  intending to be legally bound, agree as
follows:

                                   SECTION 1
                           DESCRIPTION OF TRANSACTION

         1.1  MERGER  OF  COMPANY  INTO AND WITH  ACQUIROR.  Upon the  terms and
subject to the conditions set forth in this Agreement, at the Effective Time (as
defined in Section 1.3), the Company shall be merged with and into Acquiror, and
the separate existence of the Company shall cease. Acquiror will continue as the
surviving corporation in the Merger (the "Surviving  Corporation").  The name of
the Surviving Corporation shall be RF Micro Devices, Inc.

         1.2 EFFECT OF THE MERGER.  The Merger  shall have the effects set forth
in this  Agreement and in the  applicable  provisions of the DGCL and the NCBCA.
Without limiting the generality of the foregoing,  and subject  thereto,  at the
Effective Time, all the property, rights,  privileges,  powers and franchises of
the Company shall vest in the Surviving Corporation,  and all debts, liabilities
and duties of the Company and Acquiror shall become the debts,  liabilities  and
duties of the Surviving Corporation.


         1.3 CLOSING;  EFFECTIVE  TIME.  The  consummation  of the  transactions
contemplated by this Agreement (the  "Closing")  shall take place at the offices
of Womble Carlyle Sandridge & Rice, PLLC, One West Fourth Street, Winston-Salem,
North  Carolina,  at 10:00 a.m. on a date to be  designated by the Acquiror (the
"Closing  Date"),  which shall be no later than the fifth business day after the
satisfaction  or waiver of the  latest to occur of the  conditions  set forth in
Section 6 and Section 7 (other than those conditions that by their nature are to
be fulfilled at the Closing,  but subject to the  satisfaction or waiver of such
conditions).  Subject to the provisions of this Agreement,  (i) a certificate of
merger  satisfying  the  applicable  requirements  of the  DGCL  (the  "Delaware
Certificate of Merger") shall be duly executed by the Company and by Acquiror as
the Surviving  Corporation  and  simultaneously  with or as soon as  practicable
following  the Closing  delivered  to the  Secretary  of State of  Delaware  for
filing,  and (ii) articles of merger  satisfying the applicable  requirements of
the NCBCA (the "North  Carolina  Articles of Merger")  shall be duly executed by
Acquiror and simultaneously with or as soon as practicable following the Closing
delivered  to the  Secretary of State of North  Carolina for filing.  The Merger
shall become  effective  upon the latest of: (a) the date and time of the filing
of the Delaware Certificate of Merger with the Secretary of State of Delaware as
determined under Section  103(c)(3) of the DGCL, or (b) the date and time of the
filing of the North  Carolina  Articles of Merger with the Secretary of State of
North Carolina as determined  under Section  55D-14(a)(1) of the NCBCA,  and (c)
such  other  effective  date  and  time  as may  be  specified  in the  Delaware
Certificate of Merger or the North Carolina  Articles of Merger with the consent
of Acquiror (the "Effective Time").

         1.4  ARTICLES OF  INCORPORATION  AND BYLAWS;  DIRECTORS  AND  OFFICERS.
Unless otherwise determined by Acquiror prior to the Effective Time:

         (a)  the  Articles  of  Incorporation   and  Bylaws  of  the  Surviving
Corporation  shall be those of  Acquiror as in effect  immediately  prior to the
Effective Time; and

         (b) the directors and officers of the Surviving Corporation immediately
after the Effective Time shall be the respective  individuals  who are directors
and officers of Acquiror immediately prior to the Effective Time.

         1.5 CONVERSION OF SHARES.

         (a) At the  Effective  Time,  by virtue of the Merger and  without  any
further action on the part of Acquiror, the Company or any Company Stockholder:

               (i) Any shares of Company Common Stock or Company Preferred Stock
          then held by the Company or any wholly owned Subsidiary of the Company
          shall  cease to exist,  and no  consideration  shall be  delivered  in
          exchange therefor.

               (ii) Any shares of  Company  Common  Stock or  Company  Preferred
          Stock then held by Acquiror or any other  wholly owned  Subsidiary  of
          Acquiror  shall be cancelled and  extinguished,  and no  consideration
          shall be delivered in exchange therefor.

               (iii)  Except as provided in clauses  "(i)" and "(ii)"  above and
          subject to Sections 1.5(b),  1.5(c),  1.5(d),  1.5(e) and 1.5(f), each
          share of Company Series A Preferred  Stock then  outstanding  shall be
          converted  into the right to receive a number of shares,  or  fraction
          thereof,  of Acquiror  Common Stock  (rounded to four decimal  places)
          determined  by dividing the Series A Allocation  of Acquiror  Stock by
          the Diluted Company Series A Preferred Shares. "Series A Allocation of


                                       2



          Acquiror Stock" means (1) the amount of $12,647,814.01  divided by (2)
          the average closing price per share of Acquiror Common Stock as listed
          in the WALL STREET  JOURNAL for the twenty  (20)  consecutive  trading
          days up to, but not including,  the two trading days prior to the date
          of Closing; provided, however, that if such twenty-day average closing
          price exceeds $9.50,  the average  closing price shall be deemed to be
          $9.50,  and if such  twenty-day  average  closing  price is less  than
          $6.00,  the average  closing price shall be deemed to be $6.00 (in any
          case,  "Average  Price").  "Diluted Company Series A Preferred Shares"
          means  the sum of (1)  the  number  of  shares  of  Company  Series  A
          Preferred Stock  outstanding at the Effective Time plus (2) the number
          of shares of Company  Series A Preferred  Stock issuable upon exercise
          of any warrants or other rights to acquire  Company Series A Preferred
          Stock outstanding as of the Effective Time.

               (iv)  Except as provided  in clauses  "(i)" and "(ii)"  above and
          subject to Sections 1.5(b),  1.5(c),  1.5(d),  1.5(e) and 1.5(f), each
          share of Company Series B Preferred  Stock then  outstanding  shall be
          converted  into the right to receive a number of shares,  or  fraction
          thereof,  of Acquiror  Common Stock  (rounded to four decimal  places)
          determined  by dividing the Series B Allocation  of Acquiror  Stock by
          the Diluted Company Series B Preferred Shares. "Series B Allocation of
          Acquiror Stock" means (1) the amount of $28,486,863.64  divided by (2)
          the Average Price.  "Diluted Company Series B Preferred  Shares" means
          the sum of (1) the  number  of shares of  Company  Series B  Preferred
          Stock  outstanding at the Effective Time plus (2) the number of shares
          of Company  Series B Preferred  Stock  issuable  upon  exercise of any
          warrants or other rights to acquire  Company Series B Preferred  Stock
          outstanding as of the Effective Time.

               (v)  Except as  provided  in clauses  "(i)" and "(ii)"  above and
          subject to Sections 1.5(b),  1.5(c),  1.5(d),  1.5(e) and 1.5(f), each
          share of Company Series C Preferred  Stock then  outstanding  shall be
          converted  into the right to receive a number of shares,  or  fraction
          thereof,  of Acquiror  Common Stock  (rounded to four decimal  places)
          determined  by dividing the Series C Allocation  of Acquiror  Stock by
          the  Company  Series C  Preferred  Shares.  "Series  C  Allocation  of
          Acquiror Stock" means (1) the amount of $73,865,322.35  divided by (2)
          the  Average  Price.  "Company  Series C Preferred  Shares"  means the
          number of shares of Company  Series C Preferred  Stock  outstanding at
          the Effective Time.

               (vi)  Except as provided  in clauses  "(i)" and "(ii)"  above and
          subject to Sections 1.5(b),  1.5(c),  1.5(d),  1.5(e) and 1.5(f), each
          share of Company Common Stock then outstanding shall be converted into
          the right to  receive a number of  shares,  or  fraction  thereof,  of
          Acquiror Common Stock (rounded to four decimal  places)  determined by
          dividing  the  Common  Allocation  of  Acquiror  Stock by the  Diluted
          Company Common Shares. "Common Allocation of Acquiror Stock" means (1)
          $18,000,000 divided by (2) the Average Price.  "Diluted Company Common
          Shares"  means the sum of (1) the number of shares of  Company  Common
          Stock  outstanding at the Effective Time plus (2) the number of shares
          of Company Common Stock issuable upon exercise of Company  Options (as
          defined in Section  2.3(b)),  warrants or any other  rights to acquire
          Company Common Stock outstanding at the Effective Time.

         (b) The Acquiror  Common Stock  issuable at the Effective Time pursuant
to Sections  1.5(a)(iii)  through  1.5(a)(vi) (as such amount may be adjusted in
accordance   with  this   Section   1.5(b))  is   referred  to  as  the  "Merger
Consideration."  If, between the date of this Agreement and the Effective  Time,


                                       3



the  outstanding  shares of Acquiror  Common  Stock are changed into a different
number or class of shares by reason of any stock split, stock dividend,  reverse
stock split,  reclassification,  recapitalization or other similar  transaction,
then the Merger Consideration shall be appropriately adjusted.

         (c) If any shares of Company  Common Stock or Company  Preferred  Stock
outstanding  immediately prior to the Effective Time are unvested or are subject
to a  repurchase  option,  risk of  forfeiture  or  other  condition  under  any
applicable  restricted  stock  purchase  agreement or other  agreement  with the
Company or under which the Company has any  rights,  then,  in addition  to, and
without  affecting the application of Section 1.13 or 5.3(b) hereof,  the shares
of Acquiror  Common Stock  issued in exchange for such shares of Company  Common
Stock or Company  Preferred  Stock will also be unvested and subject to the same
repurchase option,  risk of forfeiture or other condition,  and the certificates
representing such shares of Acquiror Common Stock may accordingly be marked with
appropriate  legends.  The Company shall take all reasonable  action that may be
necessary  to ensure  that,  from and  after the  Effective  Time,  Acquiror  is
entitled to exercise any such repurchase  option or other right set forth in any
such restricted stock purchase agreement or other agreement.

         (d) As  soon  as  reasonably  practicable  after  the  Effective  Time,
Acquiror  shall  distribute  to the Escrow Agent a certificate  or  certificates
representing  that  number of  shares  of  Acquiror  Common  Stock  equal to (1)
$13,300,000 divided by (2) the Average Price (the "Escrow Shares"),  which shall
be  registered  in the name of the  Escrow  Agent  as  nominee  for the  Company
Stockholders,  and will be held in escrow  pursuant  to the terms of the form of
Escrow  Agreement  attached  hereto as  Exhibit  B, with such  changes as may be
reasonably requested by the Escrow Agent thereunder.  The Escrow Shares shall be
withheld on a pro rata basis from the shares of Acquiror  Common Stock  issuable
in respect of each share of Company  Common  Stock and Company  Preferred  Stock
outstanding  as of the Effective Time and held by the Company  Stockholders  (as
defined below) pursuant to Section  1.5(a)(iii)  through (vi) hereof. The Escrow
Shares shall be held in escrow and shall be available to compensate Acquiror for
certain  damages as  provided  in the Escrow  Agreement  and to  compensate  the
Stockholders'  Representative  as set forth in Section 1.8(e). To the extent not
used for such  purposes,  such  Escrow  Shares  shall be  released to the record
holders of Company Common Stock and Company Preferred Stock immediately prior to
the Effective Time other than such Persons who hold Dissenting Stock (as defined
in Section 1.5(f)) and who have not failed to perfect,  effectively withdrawn or
lost their right to appraisal of such shares (the "Company  Stockholders"),  all
as provided in the Escrow Agreement.  The remaining Merger Consideration will be
distributed in the same proportions as provided in Sections  1.5(a)(iii) through
1.5(a)(vi)  to the  Company  Stockholders  as  soon  as  reasonably  practicable
following the Effective Time in accordance with Section 1.7.

         (e) No  fractional  shares of Acquiror  Common Stock shall be issued in
connection with the Merger, and no certificates or scrip for any such fractional
shares shall be issued.  The aggregate number of shares of Merger  Consideration
issuable to any holder of Company  Common Stock or Company  Preferred  Stock who
would  otherwise be entitled to receive a fraction of a share of Acquiror Common
Stock (after aggregating all fractional shares of Acquiror Common Stock issuable
to such holder)  shall be rounded,  up or down,  to the nearest  number of whole
shares of Acquiror Common Stock.

         (f) Notwithstanding any provision of this Agreement to the contrary, if
and to  the  extent  required  by the  DGCL  and  Section  2115  of the  General
Corporation  Law of California  ("GCLC"),  shares of Company Common Stock and/or


                                       4


Company Preferred Stock that are issued and outstanding immediately prior to the
Effective  Time and which are held by holders of such  shares of Company  Common
Stock and/or Company Preferred Stock, as applicable, who have properly exercised
appraisal  rights with respect  thereto (the  "Dissenting  Stock") in accordance
with Section 262 of the DGCL or Section 2115 of the GCLC, as  applicable,  shall
not  be  converted  into  the  right  to  receive  any  portion  of  the  Merger
Consideration,  and each  holder of such  shares of  Dissenting  Stock  shall be
entitled to receive  payment of the appraised value of such shares of Dissenting
Stock in  accordance  with the  provisions of Section 262 of the DGCL or Section
2115 of the GCLC, as applicable,  unless and until such holder fails to perfect,
effectively  withdraws  or otherwise  loses its right to  appraisal  and payment
under the DGCL or the GCLC, as  applicable.  If, after the Effective  Time,  any
such holder fails to perfect,  effectively  withdraws or loses such right,  such
shares of  Dissenting  Stock  shall  thereupon  be  treated  as if they had been
converted  into and have become  exchangeable  for, at the Effective  Time,  the
right to receive a portion of the Merger Consideration  determined in accordance
with Sections 1.5(a)-(e) above,  without any interest thereon. The Company shall
give  Acquiror  prompt  notice  of  any  demands  received  by the  Company  for
appraisals of shares of Dissenting Stock. The Company shall not, except with the
prior written consent of Acquiror,  make any payment with respect to any demands
for appraisals or offer to settle or settle any such demands, and Acquiror shall
have the right to participate in all  negotiations  and proceedings with respect
to such  demands.  If any holder of  Dissenting  Stock  receives  payment of the
appraised value of its Dissenting  Stock in an aggregate amount in excess of the
Average  Price  times the number of shares of Acquiror  Common  Stock that would
have been issuable to such holder  pursuant to Section  1.5(a),  notwithstanding
anything to the  contrary in this  Agreement,  such excess shall be treated as a
Loss  indemnifiable  by the Company  Stockholders in accordance with Section 8.1
hereof.

         1.6 CLOSING OF THE COMPANY'S TRANSFER BOOKS. At the Effective Time: (a)
all shares of Company  Common  Stock and  Company  Preferred  Stock  outstanding
immediately  prior to the  Effective  Time shall  automatically  be canceled and
retired and shall cease to exist,  and all holders of certificates  representing
shares of Company Common Stock and Company Preferred Stock that were outstanding
immediately  prior to the  Effective  Time  shall  cease to have any  rights  as
stockholders of the Company except as expressly provided in Section 1.5(f) above
and the right to receive Merger  Consideration  and Escrow  Shares;  and (b) the
stock  transfer  books of the Company shall be closed with respect to all shares
of Company  Common Stock and Company  Preferred  Stock  outstanding  immediately
prior to the Effective  Time. No further  transfer of any such shares of Company
Common  Stock or Company  Preferred  Stock shall be made on such stock  transfer
books  after  the  Effective  Time.  If,  after  the  Effective  Time,  a  valid
certificate  previously  representing  any  shares of  Company  Common  Stock or
Company  Preferred  Stock (a "Company  Stock  Certificate")  is presented to the
Surviving  Corporation,  such Company  Stock  Certificate  shall be canceled and
shall be exchanged as provided in Section 1.7.

         1.7 EXCHANGE OF CERTIFICATES.

         (a)  Acquiror's  transfer  agent  shall  act  as  exchange  agent  (the
"Exchange Agent") in the Merger.

         (b) Promptly after the Effective Time, Acquiror shall make available to
the Exchange Agent for exchange in accordance  with this Section 1, through such
reasonable procedures as Acquiror may adopt, the shares of Acquiror Common Stock
issuable  pursuant to Section 1.5 (provided that delivery of any shares that are
subject  to  vesting  may  be  in  book  entry  form  only  until  such  vesting
restrictions  have lapsed,  following  which time such shares shall be delivered


                                       5


promptly to the holder  thereof) in exchange for shares of Company  Common Stock
and Company Preferred Stock outstanding  immediately prior to the Effective Time
(less the number of Escrow Shares).

         (c)  Promptly  after the  Effective  Time,  Acquiror  will mail to each
Company Stockholder whose shares were converted into the right to receive shares
of the Merger  Consideration,  (i) a letter of transmittal in customary form and
containing  such  provisions  as Acquiror may  reasonably  specify  (including a
provision  confirming  that  delivery  of Company  Stock  Certificates  shall be
effected,  and risk of loss and title to Company Stock  Certificates shall pass,
only upon delivery of such Company  Stock  Certificates  to Acquiror),  and (ii)
instructions for use in effecting the surrender of Company Stock Certificates in
exchange for certificates  representing Acquiror Common Stock. Upon surrender of
a Company  Stock  Certificate  to Acquiror for  exchange,  together  with a duly
executed  letter of  transmittal  and such other  documents as may be reasonably
required by Acquiror,  (1) the holder of such Company Stock Certificate shall be
entitled to receive in exchange  therefor a certificate  representing the number
of whole shares of Acquiror Common Stock (less the Escrow Shares attributable to
such  holder)  that  such  holder  has the  right  to  receive  pursuant  to the
provisions of Section 1.5 (after  taking into account the  provisions of Section
1.5(d)), and (2) the Company Stock Certificate so surrendered shall be canceled.
Until  surrendered  as  contemplated  by this  Section 1.7,  each Company  Stock
Certificate  shall be deemed,  from and after the  Effective  Time, to represent
only the right to receive  shares of Acquiror  Common Stock as  contemplated  by
Section 1.5. If any Company Stock  Certificate  shall have been lost,  stolen or
destroyed,  Acquiror may, in its discretion and as a condition  precedent to the
issuance of any  certificate  representing  Acquiror  Common Stock,  require the
owner of such lost,  stolen or destroyed Company Stock Certificate to provide an
appropriate  affidavit  and to agree to indemnify  against any claim that may be
made against Acquiror or the Surviving  Corporation with respect to such Company
Stock  Certificate.  Prior to the Effective  Time,  Acquiror will deliver to the
Company  sufficient  quantities of such letter of transmittal  and  instructions
such that the holders may tender such  letter of  transmittal  at the  Effective
Time.

         1.8 STOCKHOLDERS' REPRESENTATIVE.

         (a) In order to efficiently  administer the  transactions  contemplated
hereby  occurring after the Effective  Time,  including  without  limitation the
defense and/or  settlement of any claims for which the Company  Stockholders may
be required to indemnify Acquiror and/or the Surviving  Corporation  pursuant to
Section 8 hereof, each Company Stockholder shall upon approval of the Merger and
the adoption of this Agreement be deemed,  whether or not he, she or it voted in
favor of the Merger and this Agreement,  to designate  Robert B. Abbott as their
representative (the "Stockholders' Representative").

         (b) The  Company  Stockholders  by the  approval  of the Merger and the
adoption of this Agreement authorize the Stockholders' Representative, after the
Effective Time, (i) to take all action  necessary in connection with the defense
and/or  settlement  of any  claims  for which the  Company  Stockholders  may be
required to indemnify  Acquiror  and/or the  Surviving  Corporation  pursuant to
Section 8 hereof,  (ii) to give and  receive  all  notices  required to be given
under  this  Agreement,  and (iii) to take any and all  additional  action as is
contemplated  to be taken by or on behalf  of the  Company  Stockholders  by the
terms of this Agreement.

                                       6


         (c) In the event that the Stockholders'  Representative  dies,  becomes
unable to perform  his  responsibilities  hereunder,  is removed by the  Company
Stockholders who  beneficially  own a majority of the Escrow Shares,  or resigns
from such position,  the Company Stockholders who beneficially own a majority of
the Escrow Shares are authorized to and shall select another  representative  to
fill such vacancy and such substituted  representative shall be deemed to be the
Stockholders'  Representative  for  all  purposes  of  this  Agreement  and  the
documents  delivered pursuant hereto.  Acquiror shall be entitled to rely on the
decision of the Stockholders'  Representative  named herein (or any successor as
hereafter  provided)  until  it  is  notified  in  writing  that  a  replacement
Stockholders' Representative has been elected.

         (d) All  decisions  and  actions by the  Stockholders'  Representative,
including   without   limitation   any  agreement   between  the   Stockholders'
Representative  and Acquiror relating to the defense or settlement of any claims
for which the Company  Stockholders may be required to indemnify Acquiror and/or
the Surviving  Corporation  pursuant to Section 8 hereof,  shall be binding upon
all of the Company Stockholders, and no Company Stockholder shall have the right
to object, dissent, protest or otherwise contest the same.

         (e) The  Stockholders'  Representative  shall not have any liability to
any of the  parties  hereto  or the  Company  Stockholders  for any act  done or
omitted hereunder as Stockholders' Representative while acting in good faith and
in the exercise of reasonable judgment,  and any act done or omitted pursuant to
the advice of counsel  shall be  conclusive  evidence  of such good  faith.  The
Company Stockholders shall severally indemnify the Stockholders'  Representative
and hold it harmless against any loss, liability or expense incurred without bad
faith on the part of the Stockholders'  Representative  and arising out of or in
connection with the acceptance or administration  of its duties  hereunder.  The
Stockholders'  Representative  shall be  reimbursed  for all costs and  expenses
incurred in the performance of its duties by the Company Stockholders  severally
and out of the Escrow Shares and in accordance with the procedures  described in
the Escrow Agreement;  PROVIDED, HOWEVER, in no event shall the aggregate amount
reimbursed out of the Escrow Shares exceed $100,000.00.

         (f) Upon  approval of the Merger and the  adoption  of this  Agreement,
each Company Stockholder shall be deemed,  whether or not he, she or it voted in
favor of this Agreement, to agree, in addition to the foregoing, that:

               (i) Acquiror and/or the Surviving  Corporation  shall be entitled
          to  rely  conclusively  on  the  instructions  and  decisions  of  the
          Stockholders'  Representative  as to the  settlement of any claims for
          indemnification by Acquiror and/or the Surviving  Corporation pursuant
          to Section 8 hereof,  or any other actions required or permitted to be
          taken  by the  Stockholders'  Representative  hereunder,  and no party
          hereunder  shall have any cause of action against  Acquiror and/or the
          Surviving  Corporation  for any  action  taken  in  reliance  upon the
          instructions or decisions of the Stockholders' Representative;

               (ii) all actions, decisions and instructions of the Stockholders'
          Representative  as authorized  herein shall be conclusive  and binding
          upon all of the Company  Stockholders and no Company Stockholder shall
          have any cause of action against the Stockholders'  Representative for
          any  action  taken,   decision  made  or  instruction   given  by  the
          Stockholders'  Representative under this Agreement, except for the bad
          faith  of the  Stockholders'  Representative  in  connection  with the
          matters described in this Section 1.8;

                                       7


               (iii) the  provisions  of this  Section 1.8 are  independent  and
          severable,  are  irrevocable and coupled with an interest and shall be
          enforceable  notwithstanding  any rights or remedies  that any Company
          Stockholder may have in connection with the transactions  contemplated
          by this Agreement;

               (iv) remedies  available at law for any breach of the  provisions
          of  this  Section  1.8 are  inadequate;  therefore,  Acquiror  and the
          Surviving  Corporation and the Stockholders'  Representative  shall be
          entitled to temporary  and  permanent  injunctive  relief  without the
          necessity of proving  damages if either  Acquiror and/or the Surviving
          Corporation or the  Stockholders'  Representative  brings an action to
          enforce the provisions of this Section 1.8; and

               (v) the grant of  authority  provided  for in this Section 1.8 is
          coupled  with an  interest  and shall be  irrevocable  and survive the
          death,   incompetency,   dissolution  or  bankruptcy  of  any  Company
          Stockholder  and shall be binding  upon the  executors,  heirs,  legal
          representatives,  personal  representatives,  successor  trustees  and
          successors  of each Company  Stockholder,  and any  references in this
          Agreement to a Company  Stockholder or the Company  Stockholders shall
          mean and include the  successors to the Company  Stockholder's  rights
          hereunder,  whether pursuant to testamentary disposition,  the laws of
          descent and distribution or otherwise.

         1.9 TAX  CONSEQUENCES.  For federal income tax purposes,  the Merger is
intended to constitute a reorganization  within the meaning of Section 368(a) of
the Code. The parties to this  Agreement  hereby adopt this Agreement as a "plan
of reorganization"  within the meaning of Sections  1.368-2(g) and 1.368-3(a) of
the United States Treasury Regulations.

         1.10  CERTAIN  PAYMENTS.   Each  of  the  Acquiror  and  the  Surviving
Corporation  shall be entitled  to deduct and  withhold  from any  consideration
payable or  otherwise  deliverable  pursuant to this  Agreement to any holder or
former holder of Company Common Stock or Company Preferred Stock such amounts as
may be  required to be  deducted  or  withheld  therefrom  under the Code or any
provision of state, local or foreign tax law or under any other applicable Legal
Requirement  and to collect  Forms W-8 or W-9, as  applicable,  from the Company
Stockholders.  To the extent such  amounts are so  deducted  or  withheld,  such
amounts  shall be treated for all purposes  under this  Agreement as having been
paid to the Person to whom such amounts would otherwise have been paid.  Neither
Acquiror nor the Surviving  Corporation  shall be liable to any holder or former
holder of Company Common Stock or Company Preferred Stock or to any other person
with  respect  to  any  shares  of  Acquiror   Common  Stock  (or  dividends  or
distributions with respect thereto),  or for any cash amounts,  delivered to any
public official pursuant to any applicable  abandoned  property law, escheat law
or similar Legal Requirement.

         1.11  STRUCTURE.  Notwithstanding  the  foregoing  provisions  of  this
Section 1, Acquiror may elect, by written notice  delivered to the Company,  and
upon the terms and subject to the conditions set forth in this  Agreement,  that
instead of merging the Company into Acquiror,  a direct wholly owned  subsidiary
of  Acquiror  may merge with and into the  Company or the  Company may be merged
with and into a wholly owned  subsidiary of Acquiror;  provided that no material
delay  or  adverse  effect  (including  on  the  treatment  of the  Merger  as a
"reorganization"  under Section 368(a) of the Code) on the Company Stockholders,
or to the Merger or the other transactions  contemplated hereby results from the
making of such election and provided  further that such election may not be made
after the earlier of the date of (i) the filing of the permit application as set
forth in Section 5.9 or (ii) the vote by the Company Stockholders approving such


                                       8


Merger. In such event,  references in this Agreement to the "Merger" shall refer
to the  merger  described  in this  Section  1.11 and none of the  Company's  or
Acquiror's  representations,  warranties or covenants shall be affected thereby,
except to the extent necessary to conform to the Merger  structure  contemplated
by this Section 1.11.

         1.12 FURTHER  ACTION.  If, at any time after the  Effective  Time,  any
further  action is  determined by Acquiror to be necessary or desirable to carry
out the purposes of this  Agreement or to vest the  Surviving  Corporation  with
full  right,  title and  possession  of and to all  rights and  property  of the
Company, the officers and directors of the Surviving  Corporation shall be fully
authorized (in the name of the Company and otherwise) to take such action.

         1.13 LOCK-UP.

         (a) Except as set forth  below,  each Company  Stockholder,  during the
Restricted Period applicable to such Company Stockholder,  shall not, during the
Restricted Period:

               (i) offer, sell,  contract to sell,  pledge,  grant any option to
          purchase,  make any short sale or otherwise  dispose of (or enter into
          any transaction  which is designed to, or might reasonably be expected
          to,  result  in the  disposition  (whether  by actual  disposition  or
          effective  economic  disposition due to cash settlement or otherwise))
          any shares of Acquiror Common Stock received in the Merger (including,
          without  limitation,  Acquiror  Common  Stock that may be deemed to be
          beneficially owned by such Company  Stockholder in accordance with the
          rules and regulations of the SEC, but excluding any shares of Acquiror
          Common  Stock  constituting  Escrow  Shares  (in  each  case,  "Merger
          Stock"), or

               (ii)  establish  or  increase  a  put   equivalent   position  or
          establish, liquidate or decrease a call equivalent position within the
          meaning of  Section  16 of the  Securities  Exchange  Act of 1934,  as
          amended,  and  the  rules  and  regulations  of  the  SEC  promulgated
          thereunder,  with respect to any shares of Merger  Stock,  in any case
          without the prior written consent of Acquiror;

PROVIDED,  HOWEVER,  that subject to the  provisions of this Section  1.13,  (A)
immediately  following the Effective Time, a Company  Stockholder may sell up to
1/3 of its  shares of  Merger  Stock and (B) (x) with  respect  to Merger  Stock
issued in exchange for Company Preferred Stock,  beginning 60 days subsequent to
the  Effective  Time,  such  holder  may sell up to 1/3 of its  shares of Merger
Stock,  together with any shares specified in (A) above; and (y) with respect to
Merger Stock  issued in exchange  for Company  Common  Stock,  beginning  twelve
months  subsequent to the Effective  Time, such holder may sell up to 1/3 of its
shares of Merger Stock, together with any shares specified in Section (A) above.
For  purposes  of  determining  which  shares  of  Merger  Stock  may  be  sold,
transferred,  or otherwise  disposed of in accordance with this Section 1.13(a),
those  shares of Merger Stock not subject,  or no longer  subject,  to any other
restrictions  or forfeiture  provisions of this Agreement or any other agreement
applicable  to the Merger  Stock (the "Other  Restrictions")  shall be the first
shares  available for sale in accordance with this Section 1.13. For purposes of
this Section  1.13,  "Restricted  Period"  shall mean (i) with respect to Merger
Stock issued in exchange for Company  Preferred  Stock,  120 days, and (ii) with
respect to Merger Stock issued in exchange for Company Common Stock,  24 months.
The provisions of this Section 1.13 shall be in addition to (and not in lieu of)
any Other Restrictions.

                                       9


         (b) Sales of any  shares of Merger  Stock  shall  only be  accomplished
through  one of four  designated  active  market  makers  ("Market  Makers")  in
Acquiror Common Stock (excluding  wholesalers)  identified by Acquiror from time
to time in writing to Acquiror's  stock transfer  agent and otherwise  available
from Acquiror's  secretary upon request.  Acquiror initially has designated Banc
of America  Securities  LLC, Credit Suisse First Boston  Corporation,  JP Morgan
Chase & Co. and Merrill  Lynch & Co.,  Inc. as its Market  Makers as of the date
hereof.

         (c)  Notwithstanding  anything  herein to the  contrary,  (i) shares of
Merger Stock issued in exchange for Company  Preferred  Stock may be distributed
by  a  Company  Stockholder  which  is  an  Entity  to  its  partners,  members,
stockholders  or other equity owners (each an "Equity  Recipient")  and (ii) any
Company Stockholder may make bona fide gifts of Merger Stock to immediate family
members or similar transfers for estate planning purposes (a "Family Recipient")
in a  transaction  that does not  constitute a "sale" as that term is defined in
Section  2(a)(3) of the  Securities  Act, as amended,  provided that each Family
Recipient agrees to be bound by the provisions of this Section 1.13 with respect
to any  Acquiror  Common  Stock  received  from a Company  Stockholder.  As used
herein,  "immediate  family" shall mean any  relationship by blood,  marriage or
adoption  not more  remote  than  first  cousin.  In the  case of a  transaction
involving an Equity  Recipient,  the  provisions  of this Section 1.13 shall not
bind any Equity  Recipient  with respect to any shares of Merger Stock  received
from the applicable Company Stockholder.

         (d) Nothing in this  Section 1.13 shall  prevent a Company  Stockholder
from hedging its shares of Merger Stock issued in exchange for Company Preferred
Stock, which shall include  establishing or increasing a put equivalent position
or establishing,  liquidating or decreasing a call equivalent position,  IF such
transactions are accomplished through a Market Maker,  provided that any Company
Stockholder  who is an employee of Acquiror or any  Subsidiary  of Acquiror must
comply  with any policy  adopted  by  Acquiror  or any  Subsidiary  of  Acquiror
generally applicable to its employees regarding hedging,  short sales or similar
transactions.

         (e)  Each  Company   Stockholder  shall  certify  compliance  with  the
requirements of this Section 1.13 in writing to Acquiror's  stock transfer agent
in  connection  with  the  sale  of any  shares  of  Merger  Stock.  Appropriate
restrictive  legends shall be placed on certificates  representing the shares of
Merger Stock subject to this Section  1.13,  and such shares shall be subject to
the entry of stop-transfer orders.

                                   SECTION 2
                  REPRESENTATIONS AND WARRANTIES OF THE COMPANY

         Except as set forth in the Company Disclosure  Schedule attached hereto
as Exhibit C, the  Company  represents  and  warrants to Acquiror as follows (it
being  agreed  that  except as the context  otherwise  requires in Sections  2.1
through 2.5 below,  as used in this Section 2, "Company" shall be deemed to mean
each of the Company and each Company  Subsidiary  (as defined in Section  2.1(c)
below) individually (and not collectively or in the aggregate)):

         2.1 DUE ORGANIZATION, SUBSIDIARIES, ETC.

         (a) The Company is a corporation  duly organized,  validly existing and
in good  standing  under the laws of the State of Delaware and has all necessary
power and  authority:  (i) to conduct  its  business  in the manner in which its


                                       10


business is  currently  being  conducted;  (ii) to own and use its assets in the
manner in which its assets are  currently  owned and used;  and (iii) to perform
its obligations under all Contracts by which it is bound.

         (b) The Company is qualified  to do business as a foreign  corporation,
and is in good standing (in  jurisdictions  that recognize such concept),  under
the laws of all  jurisdictions  where the nature of its business  requires  such
qualification,  except  where the  failure to be so  qualified  would not have a
Material  Adverse Effect on the Company.  Part 2.1(b) of the Company  Disclosure
Schedule lists all jurisdictions where the Company is qualified to do business.

         (c)  Except  as set  forth in Part  2.1(c)  of the  Company  Disclosure
Schedule  (the  Entities  therein  listed being  hereinafter  referred to as the
"Company  Subsidiaries"),  the Company has no Subsidiaries  and does not own any
capital stock of, or any equity interest of any nature in, any other Entity. The
Company  has not agreed  and is not  obligated  to make,  nor is it bound by any
Contract under which it may become  obligated to make, any future  investment in
or capital  contribution to any other Entity.  The Company has not, at any time,
been a general partner of any general partnership,  limited partnership or other
Entity.

         2.2 CERTIFICATE OF INCORPORATION  AND BYLAWS;  CORPORATE  RECORDS.  The
Company has delivered or made available to Acquiror accurate and complete copies
of the  certificate  of  incorporation  and  bylaws,  including  all  amendments
thereto,  of the Company and all Company  Subsidiaries.  The minute books of the
Company and all Company Subsidiaries are true, correct,  complete and current in
all material respects and contain records of all material actions taken by their
respective stockholders and board of directors (and committees thereof), and all
signatures  contained  therein  are the true  signatures  of the  persons  whose
signatures  they purport to be. The stock ledgers of the Company and all Company
Subsidiaries are true, correct,  complete and current in all respects.  Part 2.2
of the Company Disclosure  Schedule sets forth a true, correct and complete list
of the names and titles of all  officers  and  directors  of the Company and all
Company Subsidiaries.

         2.3 CAPITALIZATION, ETC.

         (a) The  authorized  capital  stock of the  Company  consists  of:  (i)
47,235,036  shares of Company Common Stock, of which 6,296,318  shares have been
issued and are outstanding as of the date of this Agreement; and (ii) 34,827,484
shares of Company  Preferred  Stock,  of which (x)  7,310,000  shares  have been
designated  Series  A  Preferred  Stock,  of  which  7,250,000  are  issued  and
outstanding  as of the date of this  Agreement,  (y) 6,491,228  shares have been
designated  as Series B  Preferred  Stock,  6,491,288  of which are  issued  and
outstanding as of the date of this Agreement and (z) 20,966,315 shares have been
designated  as Series C  Preferred  Stock,  20,631,578  of which are  issued and
outstanding as of the date of this Agreement.  All of the outstanding  shares of
Company Common Stock and each series of Company  Preferred  Stock have been duly
authorized and validly issued, and are fully paid and nonassessable. Part 2.3(a)
of the  Company  Disclosure  Schedule  sets  forth the name and  address of each
Company  Stockholder,  and the number of shares of Company Common Stock and each
series of Company  Preferred Stock held by each Company  Stockholder.  Except as
set forth in Part 2.3(a) of the  Company  Disclosure  Schedule:  (i) none of the
outstanding  shares  of  Company  Common  Stock or  Company  Preferred  Stock is
entitled or subject to any preemptive right,  right of  participation,  right of
maintenance or any similar right; (ii) none of the outstanding shares of Company
Common Stock or Company Preferred Stock is subject to any right of first refusal


                                       11


in favor of the Company;  and (iii) there is no Company Contract relating to the
voting or registration of, or restricting any Person from  purchasing,  selling,
pledging or otherwise disposing of (or granting any option or similar right with
respect to), any shares of Company Common Stock or Company  Preferred Stock. The
Company is not under any obligation,  and is not bound by any Contract  pursuant
to which it may become obligated, to repurchase, redeem or otherwise acquire any
outstanding shares of Company Common Stock or Company Preferred Stock.

         (b) As of the  date of this  Agreement,  7,065,000  shares  of  Company
Common Stock have been reserved for issuance under the 1999 Stock Plan, of which
options covering 3,397,023 shares have been granted in accordance  therewith and
are currently outstanding. (Stock options granted by the Company pursuant to the
foregoing  plan are referred to in this  Agreement as "Company  Options.")  Part
2.3(b) of the Company Disclosure  Schedule sets forth the following  information
with  respect  to  each  Company  Option  outstanding  as of the  date  of  this
Agreement:  (i) the  particular  plan pursuant to which such Company  Option was
granted;  (ii) the name of the  optionee;  (iii) the number of shares of Company
Common Stock  subject to such Company  Option;  (iv) the exercise  price of such
Company Option; (v) the date on which such Company Option was granted;  (vi) the
applicable  vesting  schedules,  and the extent to which such Company  Option is
vested and exercisable as of the date of this  Agreement;  and (vii) the date on
which such Company Option  expires.  The Company has delivered or made available
to Acquiror  accurate  and  complete  copies of all plans  pursuant to which the
Company  has ever  granted  stock  options,  and the forms of all  stock  option
agreements evidencing such options. There are no outstanding or authorized stock
appreciation, phantom stock or similar rights with respect to the Company.

         (c)  Except  as set  forth in Part  2.3(c)  of the  Company  Disclosure
Schedule,  as of the  date  of  this  Agreement  there  is no:  (i)  outstanding
subscription,   option,  call,  warrant  or  right  (whether  or  not  currently
exercisable)  to acquire any shares of the capital stock or other  securities of
the Company; (ii) outstanding security,  instrument or obligation that is or may
become  convertible  into or exchangeable for any shares of the capital stock or
other securities of the Company,  except for Company Options;  (iii) stockholder
rights  plan (or  similar  plan  commonly  referred  to as a  "poison  pill") or
Contract under which the Company is or may become obligated to sell or otherwise
issue any shares of its capital stock or any other securities; or (iv) condition
or circumstance  that may give rise to or provide a basis for the assertion of a
claim by any Person to the effect  that such  Person is  entitled  to acquire or
receive any shares of capital stock or other securities of the Company.

         (d) All  outstanding  shares of Company Common Stock,  all  outstanding
shares of Company Preferred Stock and all outstanding  Company Options have been
issued and granted in compliance  with (i) all  applicable  securities  laws and
other  applicable  Legal  Requirements,  and (ii) all  requirements set forth in
applicable Contracts.

         (e) Resonext  Communications N.V. ("Belgian Sub") is a corporation duly
organized and validly  existing  under the laws of Belgium and has all necessary
power and  authority:  (i) to conduct  its  business  in the manner in which its
business is  currently  being  conducted;  (ii) to own and use its assets in the
manner in which its assets are  currently  owned and used;  and (iii) to perform


                                       12


its  obligations  under  all  Contracts  by which it is  bound.  000  NeoSilicon
("Russian Sub") is a limited liability company duly organized,  validly existing
and in good  standing  under  the  laws of the  Russian  Federation  and has all
necessary  power and  authority:  (i) to conduct  its  business in the manner in
which its business is currently being conducted;  (ii) to own and use its assets
in the  manner in which its assets are  currently  owned and used;  and (iii) to
perform its obligations under all Contracts by which it is bound. The authorized
capital  stock of the  Belgian  Sub  consists  of:  (i) 670  shares of  Resonext
Communications N.V. common stock, no par value per share, all of which have been
issued  and are  outstanding  as of the  date of this  Agreement  and are  owned
beneficially  and of record by the Company and David  Tahmassebi  (the  "Belgian
Shares"). The authorized charter capital of the Russian Sub consists of: (i) one
share ("dolya"),  with a nominal value of 7,819,000 Russian rubles, of which one
share has been issued and is outstanding as of the date of this Agreement and is
owned  beneficially and of record by the Company (the "Russian  Share").  All of
the Belgian Shares have been duly authorized and validly  issued,  and are fully
paid for. The Russian Share has been duly authorized and validly issued,  and is
fully paid and nonassessable.  Except as set forth in Part 2.3(e) of the Company
Disclosure Schedule: (i) none of the outstanding Belgian Shares or Russian Share
(x) is entitled or subject to any preemptive right, right of participation,  or,
only with  regard to the Russian  Share,  right of  maintenance,  or any similar
right;  or (y) is subject  to any right of first  refusal in favor of the issuer
thereof;  and (ii) there is no Contract  relating to the voting or  registration
of, or restricting the Company from purchasing,  selling,  pledging or otherwise
disposing of (or  granting any option or similar  right with respect to), any of
such shares. Except as set forth in the Company Disclosure Schedule, neither the
Belgian Sub nor the Russian Sub is under any obligation,  nor is either bound by
any Contract pursuant to which it may become obligated, to repurchase, redeem or
otherwise acquire any outstanding Belgian Shares or Russian Share. Except as set
forth in Part 2.3(e) of the Company Disclosure Schedule,  as of the date of this
Agreement there is no: (i) outstanding  subscription,  option,  call, warrant or
right  (whether  or not  currently  exercisable)  to  acquire  any shares of the
capital stock or other  securities of any Company  Subsidiary;  (ii) outstanding
security,  instrument or obligation  that is or may become  convertible  into or
exchangeable  for any shares of the  capital  stock or other  securities  of any
Company  Subsidiary;  (iii)  stockholder  rights plan (or similar plan  commonly
referred to as a "poison pill") or Contract  under which any Company  Subsidiary
is or may become  obligated to sell or otherwise issue any shares of its capital
stock or any other  securities;  or (iv) condition or circumstance that may give
rise to or  provide a basis for the  assertion  of a claim by any  Person to the
effect  that such Person is entitled to acquire or receive any shares of capital
stock or other  securities of any Company  Subsidiary.  All outstanding  Belgian
Shares and Russian Share have been issued and granted in compliance with (i) all
applicable securities laws and other applicable Legal Requirements, and (ii) all
requirements set forth in applicable Contracts.

         2.4 AUTHORIZATION OF TRANSACTION. Except as provided in Part 2.4 of the
Company Disclosure  Schedule,  the Company has all requisite power and authority
to execute and deliver this Agreement and to perform its obligations  hereunder.
The execution  and delivery of this  Agreement  and,  subject to the adoption of
this Agreement and the approval of the Merger by the Company's  stockholders  as
provided in the Company's  certificate of  incorporation or other applicable law
(the "Requisite Stockholder  Approval"),  the performance by the Company of this
Agreement and the consummation by the Company of the  transactions  contemplated
hereby have been duly and validly  authorized by all necessary  corporate action
on the part of the Company.  Without  limiting the  generality of the foregoing,
the board of directors of the Company, at a meeting duly called and held, by the
unanimous  vote of those  directors  present (i)  determined  that the Merger is
advisable,  (ii) adopted this  Agreement  and approved the Merger in  accordance
with the  provisions of the DGCL or GCLC, and (iii) directed that this Agreement
and the  Merger  be  submitted  to the  stockholders  of the  Company  for their
adoption and approval and resolved to recommend that the stockholders of Company
vote in favor of the adoption of this  Agreement and the approval of the merger.
This  Agreement has been duly and validly  executed and delivered by the Company
and,  assuming the due  authorization,  execution  and delivery by the Acquiror,


                                       13


constitutes a valid and binding obligation of the Company,  enforceable  against
the  Company  in  accordance  with its  terms,  subject  to (x) laws of  general
application relating to bankruptcy, insolvency,  reorganization,  moratorium and
the relief of  debtors,  and (y) rules of law  governing  specific  performance,
injunctive relief and other equitable remedies.

         2.5  FINANCIAL  STATEMENTS.  The Company has  previously  delivered  to
Acquiror  (i) the audited  balance  sheet of the Company as of December 31, 2001
and the related  statements of operations,  stockholders'  equity and cash flows
for the fiscal year then ended,  including the footnotes thereto,  additional or
supplemental   information   supplied  therewith  and  the  report  prepared  in
connection  therewith by the independent  certified public accountants  auditing
such financial  statements;  and (ii) the interim  unaudited balance sheet as of
August  31,  2002  (the  "Company  Unaudited  Interim  Balance  Sheet")  and the
unaudited  statement of  operations  and cash flows for the  eight-month  period
ending on that date.  Except as set forth in Part 2.5 of the Company  Disclosure
Schedule,  the documents  described in clauses (i) and (ii)  (collectively,  the
"Financial  Statements"):  (a)  are  true,  complete  and  correct  as of  their
respective  dates;  (b) are in  accordance  with the  books and  records  of the
Company;  (c) present fairly the assets,  liabilities and financial condition of
the Company as of the respective  dates  thereof,  and the results of operations
for the periods  then  ending;  and (d) have been  prepared in  accordance  with
generally accepted accounting  principles ("GAAP") applied on a consistent basis
throughout the periods involved, except for year-end adjustments and the absence
of footnotes with respect to the Company  Unaudited  Interim Balance Sheet.  Any
items of income or expense  which are  unusual or of a  nonrecurring  nature are
separately  disclosed in the Financial  Statements.  The Company has no material
liability or obligation,  whether  accrued,  absolute or contingent  that is not
reflected or reserved  against in the Company  Unaudited  Interim Balance Sheet.
Other than  liabilities  that would not be required to be disclosed  under GAAP,
the Company does not have any accrued,  contingent or other  liabilities  of any
nature, either matured or unmatured,  except for: (a) liabilities  identified or
reserved  against as such in the Company  Unaudited  Interim Balance Sheet;  (b)
liabilities  that have been incurred by the Company since August 31, 2002 in the
ordinary course of business and consistent with past practices;  (c) liabilities
incurred under this Agreement and the other agreements  contemplated hereby; and
(d) liabilities described in Part 2.5 of the Company Disclosure Schedule.

         2.6 ABSENCE OF CHANGES.  Except as set forth in Part 2.6 of the Company
Disclosure Schedule, between August 31, 2002 and the date hereof:

         (a) there has not  occurred  any event or matter  which caused or could
reasonably be expected to cause any Material Adverse Effect on the Company;

         (b) there has not been any material loss,  damage or destruction to, or
any  material  interruption  in the use of,  any of the  assets  of the  Company
(whether  or not  covered  by  insurance)  that has had or could  reasonably  be
expected to have a Material Adverse Effect on the Company;

         (c) the Company has not (i)  declared,  accrued,  set aside or paid any
dividend  or made any other  distribution  in  respect  of any shares of capital
stock, or (ii) repurchased,  redeemed or otherwise  reacquired any shares of its
capital  stock  or  other  securities  other  than  repurchases  from  employees
following their termination  pursuant to the terms of their  pre-existing  stock
option or purchase agreements;

                                       14


         (d) the Company  has not sold,  issued or granted,  or  authorized  the
issuance of, (i) any capital stock or other debt or equity security  (except for
Company  Common  Stock  issued upon the valid  exercise of  outstanding  Company
Options),  (ii) any option, warrant or right to acquire any capital stock or any
other debt or equity  security  (except for Company  Options  described  in Part
2.3(b)  or Part  4.2(b)  of the  Company  Disclosure  Schedule),  or  (iii)  any
instrument  convertible into or exchangeable for any capital stock or other debt
or equity security;

         (e) the Company has not amended or waived any of its rights  under,  or
permitted the  acceleration  of vesting under (i) any provision of the Company's
stock  option  plan,  (ii)  any  provision  of  any  agreement   evidencing  any
outstanding  Company Option,  or (iii) any restricted stock purchase  agreement,
except in any case as  otherwise  expressly  provided by any  agreement  or Plan
listed in Part 2.6(e) of the Company Disclosure Schedule;

         (f) there has been no amendment to the certificate of  incorporation or
bylaws of the  Company,  and the Company has not effected or been a party to any
merger, consolidation,  share exchange, business combination,  recapitalization,
reclassification  of  shares,  stock  split,  reverse  stock  split  or  similar
transaction;

         (g) the  Company  has  not  received  any  Acquisition  Proposal  since
September 18, 2002;

         (h) the Company has not formed any  Subsidiary  or acquired  any equity
interest or other interest in any other Entity;

         (i) the Company has not made any capital  expenditure which, when added
to all other capital  expenditures  made on behalf of the Company between August
31, 2002 and the date of this Agreement, exceeds $100,000;

         (j) except in the ordinary  course of business and consistent with past
practices,  the Company has not (i) entered into or permitted  any of the assets
owned or used by it to become  bound by any  Material  Contract  (as  defined in
Section 2.10),  or (ii) amended or  terminated,  or waived any material right or
remedy under, any Material Contract;

         (k) except in the ordinary  course of business and consistent with past
practices,  the Company has not (i)  acquired,  leased or licensed  any material
right or other  material  asset from any other  Person,  (ii) sold or  otherwise
disposed of, or leased or licensed,  any material  right or other material asset
to any other Person, or (iii) waived or relinquished any right;

         (l) the  Company  has not made any  pledge of its  assets or  otherwise
permitted any of its assets to become subject to any Encumbrance, except for (i)
non-exclusive  licenses granted to end-user  customers in the ordinary course of
business and (ii) pledges of  immaterial  assets made in the ordinary  course of
business and consistent with past practices;

         (m) the Company has not (i) lent money to any Person,  or (ii) incurred
or  guaranteed  any  indebtedness  for  borrowed  money of over  $100,000 in the
aggregate;

         (n) the Company has not (i) established or adopted any Plan (as defined
in  Section  2.14),  (ii)  caused or  permitted  any Plan to be  amended  in any
material respect except as required by any Legal Requirement, (iii) entered into
any material agreement(s) with any employee,  officer or director of the Company


                                       15


other than a transaction  entered into pursuant to a Material Contract,  or (iv)
except in the ordinary  course of business and consistent  with past  practices,
paid any bonus or made any  profit-sharing  or similar  payment to, or increased
the  amount  of  the  wages,  salary,  commissions,  fringe  benefits  or  other
compensation  or  remuneration  payable  to, any of its  directors,  officers or
employees;

         (o) the Company has not  changed  any of its methods of  accounting  or
accounting  practices in any material  respect,  except for changes  required by
GAAP;

         (p) the Company has not made any material Tax election;

         (q) the Company has not  commenced  or  otherwise  become a party to or
settled any Legal  Proceeding in which there is a reasonable  possibility  of an
outcome that could have a Material  Adverse  Effect on the Company or materially
and adversely affect Acquiror;

         (r) the Company  has not taken any other  material  action  outside the
ordinary  course of  business or  inconsistent  with past  practices  other than
negotiations  with Acquiror and its  representatives  regarding the transactions
contemplated by this Agreement; and

         (s) the Company has not agreed or  committed to take any of the actions
referred to in clauses "(c)" through  "(r)" above other than  negotiations  with
Acquiror and its representatives regarding the transactions contemplated by this
Agreement.

         2.7 TITLE TO AND SUFFICIENCY OF ASSETS.  The Company owns, and has good
and valid title to, all assets purported to be owned by it,  including:  (a) all
assets  reflected on the Company  Unaudited  Interim  Balance  Sheet (except for
assets sold or otherwise  disposed of in the ordinary  course of business  since
the date of the Company  Unaudited  Interim  Balance  Sheet);  and (b) all other
assets  reflected  in the books and records of the Company as being owned by the
Company.  The Company also has a valid leasehold or other possessory interest in
all other  properties and assets used,  operated or occupied by it which are not
owned. All of said assets,  whether owned or leased by the Company, are free and
clear of any Encumbrances, except for (i) any lien for current taxes not yet due
and payable and (ii) such  imperfections of title, liens and easements as do not
and will not materially detract from or interfere with the use of the properties
subject thereto or affected  thereby,  or otherwise  impair business  operations
involving such properties and (iii) liens securing debt that is reflected on the
Company Balance Sheet ("Permitted  Liens").  All material items of equipment and
other  tangible  assets  owned by or leased to the Company are  adequate for the
uses to which they are being put,  are in good  condition  and repair  (ordinary
wear and tear  excepted) and are adequate for the conduct of the business of the
Company in the manner in which such business is currently being conducted.

         2.8 PRODUCT WARRANTIES.  Except as described in Part 2.8 of the Company
Disclosure  Schedule and for those  warranties  mandated by Legal  Requirements,
there  are no  continuing  or  outstanding  warranties  applicable  to  goods or
products manufactured or sold, or services rendered, by the Company.

         2.9 PROPRIETARY ASSETS.

(a) Part 2.9(a)(i) of the Company  Disclosure  Schedule sets forth, with respect
to  each  Proprietary  Asset  owned  by the  Company  and  registered  with  any
Governmental  Body  or  for  which  an  application  has  been  filed  with  any
Governmental  Body, (i) a brief description of such Proprietary  Asset, and (ii)


                                       16


the  names  of the  jurisdictions  covered  by the  applicable  registration  or
application.  Part 2.9(a)(ii) of the Company Disclosure  Schedule identifies any
ongoing royalty or payment  obligations with respect to each  Proprietary  Asset
that is licensed or otherwise made available to the Company by any Person and is
material to the business of the Company (except for any  Proprietary  Asset that
is licensed to the Company  under any third  party  software  license  generally
available  to  the  public),  and  identifies  the  Contract  under  which  such
Proprietary  Asset is being licensed or otherwise made available to the Company.
The Company has good and valid  title to all of the Company  Proprietary  Assets
identified in Part  2.9(a)(i) of the Company  Disclosure  Schedule and otherwise
owned  by  the  Company,  free  and  clear  of  all  Encumbrances,   except  for
non-exclusive  licenses granted to end-user  customers in the ordinary course of
business and any lien for current taxes not yet due and payable. The Company has
a valid right to use,  license and  otherwise  exploit  all  Proprietary  Assets
identified in Part  2.9(a)(ii)  of the Company  Disclosure  Schedule.  Except as
identified in Part 2.9(a) of the Company  Disclosure  Schedule,  the Company has
not  developed  jointly  with any other  Person  any  Proprietary  Asset that is
material to the  business of the Company with respect to which such other Person
has  any  rights.  Except  as set  forth  in  Part  2.9(a)(iii)  of the  Company
Disclosure  Schedule,  there is no Company Contract pursuant to which any Person
has  any  right  (whether  or not  currently  exercisable)  to use,  license  or
otherwise exploit any Company Proprietary Asset.

         (b) The  Company  has taken  reasonable  measures  and  precautions  to
protect and  maintain  the  confidentiality,  secrecy and value of all  material
Company  Proprietary Assets (except Company Proprietary Assets whose value would
be unimpaired by disclosure).  Without limiting the generality of the foregoing,
all current and former employees, consultants and independent contractors of the
Company  who  are  or  were  materially  involved  in,  or who  have  materially
contributed to, the creation or development of any material Company  Proprietary
Asset have  executed  and  delivered to the Company an  appropriate  employment,
consulting  or other  agreement  having the effect of  assigning  such  Person's
rights in any Company  Proprietary  Asset to the  Company.  No current or former
employee, officer, director, stockholder,  consultant or independent contractor,
or any person claiming by or through any of the foregoing or succeeding to their
interests,  has any right,  claim or interest in or with  respect to any Company
Proprietary Asset.

         (c) The Company further  represents and warrants that: (i) all patents,
trademarks,  service  marks  and  copyrights  held  by the  Company  are  valid,
enforceable and subsisting;  (ii) none of the Company  Proprietary Assets and no
Proprietary  Asset that is currently  being  developed by the Company (either by
itself or with any other Person)  infringes,  misappropriates  or conflicts with
any  Proprietary  Asset  owned or used by any other  Person;  (iii)  none of the
products  that  are  or  have  been  designed,  created,  developed,  assembled,
manufactured or sold by the Company are infringing,  misappropriating  or making
any unlawful or unauthorized  use of any Proprietary  Asset owned or used by any
other  Person,  and since the  inception  of the  Company,  the  Company has not
received any written  notice or other  communication  (in writing or  otherwise)
that it has committed any actual or potential infringement,  misappropriation or
unlawful  or  unauthorized  use of, any  Proprietary  Asset owned or used by any
other  Person;  and  (iv) to the  Knowledge  of  Company,  no  other  Person  is
infringing,  misappropriating or making any unlawful or unauthorized use of, and
no  Proprietary  Asset owned or used by any other Person  infringes or conflicts
with,  any  material  Company  Proprietary  Asset.  The Company has not received
notice  from any Person  that the  Company is  infringing,  misappropriating  or
making unlawful or unauthorized use of such Person's asset(s).

                                       17


         (d) The  Company  Proprietary  Assets  constitute  all the  Proprietary
Assets  necessary to enable the Company to conduct its business in the manner in
which such business is being conducted.  The Company has not (i) licensed any of
the material Company  Proprietary Assets to any Person, or (ii) entered into any
covenant not to compete or Contract  limiting  its ability to exploit  fully any
material  Company  Proprietary  Assets or to transact  business in any market or
geographical area or with any Person.

         2.10 CONTRACTS. Part 2.10 of the Company Disclosure Schedule sets forth
a true, complete and correct list of all Material  Contracts,  true and complete
copies of which have been delivered to Acquiror by the Company.  For the purpose
of this  Agreement,  a "Material  Contract"  means any Contract  relating to the
Company  with or to any  Person  whatsoever,  other  than one  which  (a) may be
terminated  on not more than thirty (30) days notice  without  liability  to the
Company,  (b)  involves  payments by the Company in the  aggregate  of less than
$25,000, or (c) purchase orders (i) for Company products or services accepted in
the  ordinary  course of  business  or (ii) for  products  or  services  for the
operation of the  Company's  business  entered  into in the  ordinary  course of
business.  Notwithstanding  anything to the contrary,  any contract or agreement
between the Company and an officer,  director,  or employee of the Company shall
be  deemed a  Material  Contract  and  shall be  identified  in Part 2.10 of the
Company Disclosure Schedule. All of the Material Contracts are valid and in full
force and effect,  and there are not  existing or, to the  Company's  Knowledge,
claimed  defaults by any party  thereunder  and no event,  act or  omission  has
occurred  which  (with or  without  notice,  lapse of time or the  happening  or
occurrence  of any other  event)  would  result in a default  under any Material
Contract. The Company has complied in all material respects with its obligations
under the Material Contracts.

         2.11  COMPLIANCE WITH LEGAL  REQUIREMENTS.  Except as set forth in Part
2.11 of the Company Disclosure  Schedule,  the Company is in compliance with all
applicable material Legal  Requirements.  Without limiting the generality of the
foregoing,  (i) the Company has not  exported  any product or other  Proprietary
Asset in violation  of any Legal  Requirement  and (ii) to the  Knowledge of the
Company, neither the Company nor any director, officer, agent or employee of the
Company has (a) used any funds for unlawful contributions,  gifts, entertainment
or other unlawful expenses relating to political activity, (b) made any unlawful
payment to foreign or domestic  government  officials or employees or to foreign
or  domestic  political  parties or  campaigns,  or (c) made any other  unlawful
payment  which  could  reasonably  be  expected  to subject  the  Company to any
criminal or civil fine, penalty or sanction. Since the inception of the Company,
the  Company  has not  received  any  notice  or  other  communication  from any
Governmental  Body regarding any actual or possible  violation of, or failure to
comply with, any material Legal Requirement.

         2.12 GOVERNMENTAL AUTHORIZATIONS.

         (a)  Except as  provided  in Part  2.12(a)  of the  Company  Disclosure
Schedule, the Company holds all material Governmental  Authorizations  necessary
to enable  the  Company  to conduct  its  business  in the manner in which it is
currently being conducted. All such Governmental Authorizations are valid and in
full  force and  effect  and the  Company  is in  compliance  with the terms and
requirements  of such  Governmental  Authorizations.  Since the inception of the
Company, the Company has not received any notice or other communication from any
Governmental  Body regarding (i) any actual or possible  violation of or failure
to comply with any term or requirement  of any  Governmental  Authorization,  or
(ii) any actual or possible revocation,  withdrawal,  suspension,  cancellation,
termination or material modification of any Governmental Authorization.

                                       18


         (b) The  Company  has not  received  any  grant,  incentive  or subsidy
provided or made  available  to or for the benefit of the Company by any U.S. or
foreign Governmental Body or otherwise, the award of which was discretionary.

         2.13 TAX MATTERS.

         (a) Each Tax Return required to be filed by or on behalf of the Company
with any  Governmental  Body with  respect to any  taxable  period  ending on or
before the Closing Date (the "Company Returns") (i) has been or will be filed on
or before the applicable  due date  (including any extensions of such due date),
and (ii) has  been,  or will be when  filed,  prepared  in  compliance  with all
applicable  Legal  Requirements.  All amounts shown on the Company Returns to be
due on or before  the  Closing  Date have been or will be paid on or before  the
Closing Date. No claim has ever been made by a Governmental  Body to the Company
in writing in a jurisdiction where the Company does not file Tax Returns that it
is or may be subject to taxation by that jurisdiction.

         (b) All United  States,  state and local  income,  profits,  franchise,
sales,  use,  occupancy,  property,  severance,  excise,  value added,  payroll,
withholding  and other taxes,  and all taxes owing to any foreign  countries and
political subdivisions thereof (including interest,  penalties and any additions
to tax) due from or claimed to be due by each taxing authority in respect of the
Company,  or its business,  for all periods  through the date of this Agreement,
have been fully paid or adequately  provided for in the financial  statements of
the Company.  The Company has timely made and will timely make all  withholdings
of tax required to be made under all applicable  United States,  state and local
tax regulations,  and such withholdings have either been paid or will be paid to
the respective  governmental  agencies or set aside in accounts for such purpose
or accrued,  reserved  against and entered  upon the books of the  Company.  The
Company  Unaudited Interim Balance Sheet fully accrues all actual and contingent
liabilities  for Taxes with  respect to all periods  through  August 31, 2002 in
accordance  with GAAP.  The Company will  establish,  in the ordinary  course of
business  and  consistent  with its past  practices,  reserves  adequate for the
payment of all Taxes for the period  from  January 1, 2002  through  the Closing
Date.

         (c) No  examination  or audit by any  Governmental  Body of any Company
Return is currently  taking  place.  No  extension  or waiver of the  limitation
period applicable to the Company Returns has been granted (by the Company or any
other  Person),  and no such  extension  or waiver has been  requested  from the
Company.

         (d) No claim or Legal  Proceeding  is  pending  or has been  threatened
against  or with  respect to the  Company  in  respect of any Tax.  There are no
unsatisfied liabilities for Taxes (including liabilities for interest, additions
to tax and penalties thereon and related expenses) with respect to any notice of
deficiency or similar  document  received by the Company with respect to any Tax
(other than  liabilities  for Taxes asserted under any such notice of deficiency
or similar  document which are being contested in good faith by the Company with
respect to which  adequate  reserves  for payment have been  established  on the
Company  Unaudited Interim Balance Sheet and which are set forth on Part 2.13 of
the Company's Disclosure Schedule). There are no liens for Taxes upon any of the
assets of the Company except liens for current Taxes not yet due and payable.

         (e)  Except  as set forth in Part  2.13(e)  of the  Company  Disclosure
Schedule,  there is no agreement,  plan,  arrangement or other Contract covering
any  employee  or  independent  contractor  or former  employee  or  independent


                                       19


contractor  of  the  Company  that,   considered   individually   or  considered
collectively  with any  other  such  Contracts,  will,  or could  reasonably  be
expected to, give rise  directly or indirectly to the payment of any amount that
would not be deductible  pursuant to Section 280G or Section 162 of the Code (or
any comparable  provision of state or foreign Tax laws). The Company is not, and
has never been, a party to or bound by any tax indemnity agreement,  tax sharing
agreement, tax allocation agreement or similar Contract.

         2.14 EMPLOYEE AND LABOR MATTERS; BENEFIT PLANS.

         (a)  Part  2.14(a)  of the  Company  Disclosure  Schedule  contains  an
accurate  and  complete  list and  description  of all Plans (as defined  below)
maintained or sponsored by the Company  and/or to which the Company  contributes
or is  obligated to  contribute  or has any  liability  or potential  liability,
whether  direct or  indirect.  For purposes of this  Agreement,  the term "Plan"
shall  mean  any  plan,  arrangement,  agreement  or  program  which  is:  (i) a
profit-sharing,  stock bonus, deferred compensation,  bonus, stock option, stock
purchase,  pension,  retainer,  consulting,  retirement,  severance,  welfare or
incentive plan,  agreement or arrangement,  whether or not funded and whether or
not terminated;  (ii) an employment  agreement or retention  agreement;  (iii) a
personnel  policy  or  fringe  benefit  plan,  policy,  program  or  arrangement
providing for benefits or perquisites to current or former employees,  officers,
directors  or agents,  whether or not  funded,  and  whether or not  terminated,
including,  without  limitation,   benefits  relating  to  automobiles,   clubs,
vacation,  child care, parenting,  sabbatical,  sick leave, severance,  medical,
dental,  hospitalization,  life insurance and other types of insurance;  or (iv)
any other employee benefit plan as defined in Section 3(3) of ERISA,  whether or
not funded and whether or not terminated.

         (b)  The  Company  does  not  contribute  to,  have  an  obligation  to
contribute to or otherwise  have any material  liability or potential  liability
with respect to (i) any multiemployer plan as defined in Section 3(37) of ERISA,
(ii) any plan of the type  described  in  Sections  4063 and 4064 of ERISA or in
Section 413 of the Code (and regulations promulgated  thereunder),  or (iii) any
plan which provides  health,  life insurance,  accident or other  "welfare-type"
benefits to current or future retirees or former  employees or directors,  their
spouses or dependents,  other than in accordance with Section 4980B of the Code,
Sections 601 ET SEQ. of ERISA, or applicable state continuation coverage law.

         (c)  Except  as set forth in Part  2.14(c)  of the  Company  Disclosure
Schedule, none of the Plans obligates the Company to pay separation,  severance,
termination  or  similar-type  benefits  solely as a result  of any  transaction
contemplated by this Agreement.

         (d) Each Plan,  including all related trusts,  insurance  contracts and
funds,  has been  maintained,  funded  and  administered  in  compliance  in all
respects  with  its own  terms  and in all  material  respects  with  all  Legal
Requirements,  including  but not  limited  to  ERISA  and the  Code.  No  Legal
Proceedings,  claims, complaints,  charges, or demands with respect to the Plans
(other than  routine  claims for  benefits)  are  pending  or, to the  Company's
Knowledge,  threatened.  No Plan that is subject to the funding  requirements of
Section 412 of the Code or Section 302 of ERISA has  incurred  any  "accumulated
funding  deficiency"  as such term is defined in such  Sections of ERISA and the
Code,  whether or not  waived,  and each Plan has always  fully met the  funding
standards  required  under  Title I of ERISA and  Section  412 of the  Code.  No
liability  to the Pension  Benefit  Guaranty  Corporation  ("PBGC")  (except for
routine payment of premiums) has been or is expected to be incurred with respect
to any Plan that is subject to Title IV of ERISA,  no reportable  event (as such
term is  defined  in  Section  4043 of ERISA)  for which the PBGC has not waived
notice  has  occurred  with  respect  to any  such  Plan,  and the  PBGC has not


                                       20


commenced or, to the Company's  Knowledge,  threatened  the  termination  of any
Plan.  None of the assets of the  Company  are the  subject of any lien  arising
under Section 302(f) of ERISA or Section 412(n) of the Code, and the Company has
not been  required  to post any  security  pursuant  to Section  307 of ERISA or
Section  401(a)(29) of the Code.  No event has occurred and no condition  exists
that would subject the Company to any tax under Sections 4971,  4972, 4976, 4977
or 4979 of the Code or to a fine or penalty under Section 502(c) of ERISA.

         (e) With  respect to each Plan that is intended to be  qualified  under
Section 401(a) of the Code, and each trust (if any) forming a part thereof,  the
Company  has either  received  from the  Internal  Revenue  Service a  favorable
determination  letter (or opinion letter, if applicable) as to the qualification
under the Code of such Plan and tax exempt  status of such related  trust or, as
fully  identified  in Part  2.14(e)  of the  Company  Disclosure  Schedule,  has
remaining time in which to apply for such letter.

         (f) No underfunded  "defined  benefit plan" (as such term is defined in
Section  3(35) of ERISA) has been,  during the five years  preceding the Closing
Date,  transferred  out of the  controlled  group of  corporations  (within  the
meaning of Sections  414(b),  (c), (m) and (o) of the Code) of which the Company
is a member or was a member during such five-year period.

         (g) As of the Closing Date, the fair market value of the assets of each
Plan that is a tax qualified defined benefit plan equaled or exceeded, and as of
the  Closing  Date will equal or  exceed,  the  present  value of all vested and
nonvested  liabilities  thereunder  determined  in  accordance  with  reasonable
actuarial methods,  factors and assumptions applicable to a defined benefit plan
on an ongoing  basis.  With  respect to each Plan that is subject to the funding
requirements  of Section 412 of the Code and Section 302 of ERISA,  all required
contributions  for  all  periods  ending  prior  to or as of  the  Closing  Date
(including  periods  from the  first  day of the  then-current  plan year to the
Closing Date and including all  quarterly  contributions  required in accordance
with  Section  412(m) of the Code)  shall have been made.  With  respect to each
other Plan, all required payments,  premiums,  contributions,  reimbursements or
accruals  for all periods  ending  prior to or as of the Closing Date shall have
been made.

         (h)  No  prohibited  transaction  (which  shall  mean  any  transaction
prohibited  by Section 406 of ERISA and not exempt under Section 408 of ERISA or
Section 4975 of the Code, whether by statutory,  class or individual  exemption)
has  occurred  with  respect to any Plan which would  result in the  imposition,
directly or  indirectly,  of any excise tax,  penalty or other  liability  under
Section 4975 of the Code or Section 409 or 502(i) of ERISA. None of the Company,
any trustee,  administrator  or other fiduciary of any Plan, or any agent of any
of the foregoing has engaged in any  transaction  or acted or failed to act in a
manner that could  subject the Company to any material  liability  for breach of
fiduciary duty under ERISA or any Legal Requirement.

         (i) With  respect to each Plan,  all material  reports and  information
required  to be  filed  with  any  government  agency  or  distributed  to  Plan
participants  and  their  beneficiaries  have  been  duly  and  timely  filed or
distributed.

         (j) The Company has been and is presently in material  compliance  with
all of the requirements of Sections 4980B and 4980D of the Code.

                                       21


         (k) The Company does not have any material  liability as of [August 31,
2002] under any Plan that, to the extent  disclosure is required  under GAAP, is
not  reflected  on the Company  Unaudited  Interim  Balance  Sheet or  otherwise
disclosed in Part 2.14(k) of the Company Disclosure Schedule.

         (l) Neither the  consideration  nor  implementation of the transactions
contemplated under this Agreement will materially increase (i) the obligation of
the Company to make contributions or any other payments to fund benefits accrued
under the Plans as of the date of this Agreement or (ii) the benefits accrued or
payable with respect to any  participant  under the Plans  (except to the extent
benefits may be deemed increased by accelerated vesting).

         (m) With respect to each Plan,  the Company has provided  Acquiror with
true,  complete  and correct  copies of (i) all material  documents  pursuant to
which the Plans are maintained, funded and administered,  including summary plan
descriptions,  (ii) all annual  reports  (Form 5500  series)  filed with the IRS
and/or the U.S.  Department  of Labor (with  attachments),  (iii) all  actuarial
reports, if any, (iv) all financial  statements,  (v) all governmental  filings,
including, without limitation, excise tax returns and reportable events filings,
(vi) all governmental rulings,  determination letters, and opinions (and pending
requests for governmental  rulings,  determination  letters, and opinions),  and
(vii) the most  recent  valuation  (but in any case one that has been  completed
within the last calendar year) of the present and future  obligations under each
Plan that provides  post-retirement or post-employment  health,  life insurance,
accident or other "welfare-type" benefits.

         (n) Each of the  Plans  may be  amended  or  terminated  at any time by
action of the  Company's  board of  directors,  or a committee  of such board of
directors or duly authorized  officer,  in each case subject to the terms of the
Plan and compliance with all Legal Requirements.

         (o)  Except  as set forth in Part  2.14(o)  of the  Company  Disclosure
Schedule, neither the execution,  delivery or performance of this Agreement, nor
the consummation of the Merger or any of the other transactions  contemplated by
this Agreement,  will result in any material bonus, golden parachute,  severance
or other payment or obligation to any current or former  employee or director of
the Company (whether or not under any Plan), or materially increase the benefits
payable or provided under any Plan, or result in any acceleration of the time of
payment or vesting of any such benefits.  Without limiting the generality of the
foregoing,  except  as set  forth  in Part  2.14(o)  of the  Company  Disclosure
Schedule,  the consummation of the Merger will not result in the acceleration of
vesting  of any  unvested  Company  Options or shares of  Company  Common  Stock
subject to any restricted stock agreement.

         (p) Part 2.14(p) of the Company Disclosure  Schedule contains a list of
all  salaried  employees  of the Company as of the date of this  Agreement,  and
correctly  reflects,  in all material  respects,  their  salaries and applicable
bonus and commission  arrangements,  and their  positions.  The Company is not a
party to any collective bargaining contract or other Contract with a labor union
involving  any of its  employees.  Except  as set forth in Part  2.14(p)  of the
Company Disclosure  Schedule,  all of the employees of the Company are "at will"
employees.

         (q) The Company is in material  compliance  with all  applicable  Legal
Requirements and Contracts relating to employment,  employment practices, wages,
bonuses and terms and conditions of employment,  including employee compensation
matters,  and there is no unfair labor practice charge or complaint or charge of


                                       22


employment  discrimination or retaliation  against the Company pending or to the
Company's Knowledge, threatened, impending or planned.

         (r) As of the  date of this  Agreement,  the  Company  has  good  labor
relations,  and does not have any Knowledge of any facts indicating that (i) the
consummation of the Merger or any of the other transactions contemplated by this
Agreement will adversely impact the labor relations of the Company,  or (ii) any
of the employees of the Company  intends to terminate his or her employment with
the  Company.  Except as set forth in Part  2.14(r)  of the  Company  Disclosure
Schedule,  for purposes of all applicable  Legal  Requirements,  the Company has
properly  classified each person providing  services to the Company as either an
employee or an independent contractor.

         2.15  ENVIRONMENTAL  MATTERS.  The  Company is in  compliance  with all
applicable  Environmental  Laws, which compliance includes the possession by the
Company of all  permits and other  Governmental  Authorizations  required  under
applicable  Environmental  Laws,  and  compliance  with the terms and conditions
thereof.  The Company has not  received  any notice or other  communication  (in
writing  or  otherwise),  whether  from a  Governmental  Body,  citizens  group,
employee or otherwise,  that alleges that the Company is not in compliance  with
any  Environmental  Law,  and,  to  the  Company's   Knowledge,   there  are  no
circumstances  that may prevent or interfere  with the compliance by the Company
with any Environmental Law in the future.  The Company has not knowingly sent or
transported,  or arranged to send or transport,  any Materials of  Environmental
Concern to a site that,  pursuant to any  applicable  Environmental  Law (i) has
been placed on the "National  Priorities  List" of hazardous  waste sites or any
similar  state list,  (ii) is otherwise  designated or identified as a potential
site for remediation, cleanup, closure or other environmental remedial activity,
or (iii) is subject  to a Legal  Requirement  to take  "removal"  or  "remedial"
action as detailed in any  applicable  Environmental  Law or to make payment for
the cost of  cleaning  up the site.  (For  purposes of this  Section  2.15:  (i)
"Environmental Law" means any federal, state, local or foreign Legal Requirement
relating  to  pollution  or  protection  of  human  health  or  the  environment
(including ambient air, surface water,  ground water, land surface or subsurface
strata),  including  any law or regulation  relating to  emissions,  discharges,
releases or  threatened  releases of  Materials  of  Environmental  Concern,  or
otherwise relating to the manufacture, processing, distribution, use, treatment,
storage, disposal,  transport or handling of Materials of Environmental Concern;
and (ii) "Materials of  Environmental  Concern" include  chemicals,  pollutants,
contaminants, wastes, toxic substances, petroleum and petroleum products and any
other substance that is now or hereafter  regulated by any  Environmental Law or
that is otherwise a danger to health, reproduction or the environment.)

         2.16 LEGAL PROCEEDINGS; ORDERS.

         (a)  Except  as set  forth  in  Part  2.16  of the  Company  Disclosure
Schedule,  as of the date hereof, there is no pending Legal Proceeding,  and (to
the  Company's  Knowledge)  no  Person  has  threatened  to  commence  any Legal
Proceeding:  (i) that involves the Company or any of the assets owned or used by
the Company; or (ii) that challenges, or that may have the effect of preventing,
delaying, making illegal or otherwise interfering with, the Merger or any of the
other transactions contemplated by this Agreement. No event has occurred, and no
claim,  dispute or other condition or circumstance  exists that could reasonably
be expected to give rise to or serve as a basis for the commencement of any such
Legal  Proceeding.  Without limiting the generality of the foregoing,  as of the
date  hereof,  no Person has made any claim or commenced  any Legal  Proceedings
(and, to the Company's Knowledge,  no Person has threatened to make any claim or
commence any Legal  Proceeding)  involving the Company that relates  directly or


                                       23


indirectly to any  malfunction,  defect or  deficiency  in any product,  system,
program or other item of property in or with which any Company Proprietary Asset
is incorporated, used or bundled.

         (b) As of  the  date  hereof,  there  is no  order,  writ,  injunction,
judgment or decree to which the  Company,  or any of the assets owned or used by
the Company, is subject. To the Company's Knowledge,  no officer or key employee
of the  Company is subject to any order,  writ,  injunction,  judgment or decree
that prohibits such officer or other employee from engaging in or continuing any
conduct, activity or practice relating to the business of the Company.

         2.17  REAL  PROPERTY.  Part  2.17 of the  Company  Disclosure  Schedule
contains a true and correct  description of all (i) real property  leased by the
Company (the "Leased Real  Property");  (ii) leases  relating to the Leased Real
Property (collectively,  the "Real Property Leases"); (iii) Encumbrances upon or
affecting any of the  Company's  rights to or interest in any of the Leased Real
Property or any Real Property Lease; (iv) agreements,  oral or written, pursuant
to which any  person or  entity  (other  than the  Company)  leases,  subleases,
occupies or has the right to occupy any Leased Real Property; and (v) agreements
and other  undertakings,  oral or written,  to sell,  lease,  sublease,  assign,
encumber  or  otherwise  dispose of any Leased Real  Property  or Real  Property
Lease.  To the  Company's  Knowledge,  the Leased Real Property is zoned for the
various purposes for which the buildings and other improvements  located thereon
(the  "Improvements")  are  presently  being used,  and such uses thereof are in
compliance  with  all  applicable  zoning  and  land use  laws,  ordinances  and
regulations.  All  Improvements  are  in  good  repair  and  in  good  operating
condition,  ordinary  wear and tear  excepted,  and free from  latent and patent
defects. No part of any Improvement encroaches on any real property not included
in the Leased Real Property.

         2.18 INSURANCE. Part 2.18 of the Company Disclosure Schedule sets forth
all insurance  policies and fiduciary and other bonds  maintained by the Company
with respect to the business of the Company.  Such policies and bonds are valid,
binding and enforceable in accordance with their terms and are in full force and
effect, and all premiums due thereon have been paid and will be paid through the
Closing Date.

         2.19  INAPPLICABILITY OF ANTI-TAKEOVER  STATUTES;  DISSENTERS'  RIGHTS.
Except as set forth in Part 2.19 of the Company  Disclosure  Schedule,  no state
takeover  statute or similar statute or regulation  applies or purports to apply
to the Merger, this Agreement or any of the transactions contemplated hereby. No
statute and nothing in the  certificate  of  incorporation  or the bylaws of the
Company provides or would provide to any person,  including  without  limitation
the holders of Company Common Stock or Company  Preferred Stock,  upon execution
of this Agreement and consummation of the transactions  contemplated  hereby and
thereby,  rights of dissent and appraisal of any kind other than those  provided
for in Section 262 of the Delaware General Corporation Law.

         2.20 NON-CONTRAVENTION;  CONSENTS.  Except as set forth in Part 2.20 of
the Company Disclosure  Schedule and except as may be required by the Securities
Act, the Exchange Act, state securities or "blue sky" laws, the Delaware General
Corporation  Law, the HSR Act and any foreign  antitrust law or regulation,  the
Company  is not and will not be  required  to make any  filing  with or give any
notice to, or to obtain any  Consent  from,  any Person in  connection  with the
execution,  delivery or performance  of this  Agreement or any other  agreements
referred to in this Agreement by the Company or the  consummation by the Company
of the Merger or any other transactions contemplated by this Agreement. Assuming


                                       24


compliance with the foregoing and receipt of the Requisite Stockholder Approval,
neither (1) the  execution,  delivery or performance of this Agreement or any of
the other agreements  referred to in this Agreement by the Company,  nor (2) the
consummation  by the  Company  of the  Merger or any of the  other  transactions
contemplated  by this  Agreement or by any other  agreement  referred to in this
Agreement,  will  directly  or  indirectly  (with or without  notice or lapse of
time):

         (a)  contravene,  conflict  with or result in a violation of (i) any of
the provisions of the certificate of incorporation or bylaws of the Company,  or
(ii) any  resolution  adopted by the board of  directors,  any  committee of the
board of directors of the Company,  or any group  holding in the  aggregate  not
less than a simple majority of the issued and outstanding shares of any class of
the outstanding  securities of the Company  (including any combination of shares
deemed to  constitute a class for voting  purposes as provided in the  Company's
Certificate of Incorporation);

         (b) contravene,  conflict with or result in a violation of, or give any
Governmental  Body or other Person the right to  challenge  the Merger or any of
the other transactions  contemplated by this Agreement or to exercise any remedy
or  obtain  any  relief  under,  any  Legal  Requirement  or  any  order,  writ,
injunction,  judgment or decree to which the Company, or any of the assets owned
or used by the Company, is subject;

         (c)  contravene,  conflict  with or result in a violation of any of the
material terms or requirements  of, or give any  Governmental  Body the right to
revoke,  withdraw,  suspend,  cancel,  terminate  or  modify,  any  Governmental
Authorization  that is held by the  Company  or that  otherwise  relates  to the
business of the Company or to any of the assets owned or used by the Company;

         (d)  except  for the  required  consents  set forth on Part 2.20 of the
Company Disclosure Schedule, contravene,  conflict with or result in a violation
or  breach  of,  or result in a default  under,  any  provision  of any  Company
Contract that is or would constitute a Material Contract, or give any Person the
right to (i) declare a default or  exercise  any remedy  under any such  Company
Contract,  (ii) a rebate,  chargeback,  penalty or change in  delivery  schedule
under any such Company Contract, (iii) accelerate the maturity or performance of
any such Company Contract, or (iv) cancel,  terminate or modify any term of such
Company Contract; or

         (e) result in the  imposition  or creation of any  Encumbrance  upon or
with respect to any asset owned or used by the Company.

         2.21 NAMES. During the term of its existence,  the Company has not been
known by or conducted  business  under any other name except as provided in Part
2.21 of the Company Disclosure Schedule.

         2.22 BANK ACCOUNT.  Part 2.22 of the Disclosure Schedule sets forth (a)
a true and complete list of the names of each bank,  trust  company,  securities
broker and other  financial  institution  at which the Company has an account or
safe deposit box or  maintains a banking,  custodial,  trading or other  similar
relationship;  and (b) a true and  complete  list and  description  of each such
account,  box and  relationship,  indicating in each case the account number and
the names of the officers,  employees,  agents or other  representatives  of the
Company having access,  signatory  power or power to give direction with respect
to such account, box or relationship.

                                       25


         2.23 FULL DISCLOSURE.  This Agreement (including the Company Disclosure
Schedule) does not, and the certificate  referred to in Section 6.5(c) will not,
(i)  contain  any  representation,  warranty  or  information  that is  false or
misleading with respect to any material fact, or (ii) omit to state any material
fact necessary in order to make the representations,  warranties and information
contained  and  to be  contained  herein  and  therein  (in  the  light  of  the
circumstances under which such representations,  warranties and information were
or will be made or provided) not false or misleading.

         2.24  AFFILIATE  TRANSACTIONS.  Except as set forth on Part 2.24 of the
Company's  Disclosure  Schedule,  the Company has not entered into, or agreed to
enter into, any Contract or transaction with any Affiliate of the Company.

         2.25  OFFICER  AND  DIRECTOR  LIABILITY.  No officer or director of the
Company has made a claim against the Company for indemnification as contemplated
in  the  DGCL,  the  Company's  Certificate  of  Incorporation,  Bylaws  or  any
applicable  insurance  policy,  nor, to the  Knowledge of the  Company,  has any
officer or director threatened to make such a claim. Further, the Company has no
Knowledge of any matter that could  reasonably  be expected to cause any officer
or director of the Company to make such a claim.

                                   SECTION 3
                   REPRESENTATIONS AND WARRANTIES OF ACQUIROR

         Except as set forth in the Acquiror Disclosure Schedule attached hereto
as Exhibit D, Acquiror represents and warrants to the Company as follows:

         3.1 DUE ORGANIZATION; SUBSIDIARIES; ETC.

         (a) Acquiror is a corporation duly organized and validly existing under
the  laws of the  State  of  North  Carolina  and has all  necessary  power  and
authority:  (i) to conduct its  business in the manner in which its  business is
currently being conducted; (ii) to own and use its assets in the manner in which
its assets are currently  owned and used;  and (iii) to perform its  obligations
under all Contracts by which it is bound.

         (b) Acquiror and each of Acquiror's  Subsidiaries  is duly qualified to
do business as a foreign corporation, and is in good standing, under the laws of
all jurisdictions  where the nature of its business requires such qualification,
except  where the  failure to be so  qualified  would not  materially  adversely
affect the operation of Acquiror's business.

         3.2 ARTICLES OF  INCORPORATION  AND BYLAWS.  Acquiror has  delivered or
made  available to the Company  accurate and complete  copies of the articles of
incorporation and bylaws of Acquiror, including all amendments thereto. Acquiror
is not in violation of its articles of incorporation or bylaws.

         3.3  CAPITALIZATION.  The authorized capital stock of Acquiror consists
of: (i) 500,000,000  shares of Acquiror Common Stock;  and (ii) 5,000,000 shares
of Acquiror  Preferred  Stock. As of September 28, 2002,  168,972,922  shares of
Acquiror  Common  Stock  were  issued  and  outstanding.  As of the date of this
Agreement, no shares of Acquiror Preferred Stock are issued or outstanding.  All
of the outstanding shares of Acquiror Common Stock have been duly authorized and
validly  issued,  and are fully paid and  nonassessable.  Except as set forth in
Part 3.3 of the Acquiror Disclosure Schedule: (i) none of the outstanding shares
of Acquiror Common Stock is entitled or subject to any preemptive  right,  right


                                       26


of  participation,  right of maintenance or any similar right;  (ii) none of the
outstanding  shares of  Acquiror  Common  Stock is subject to any right of first
refusal in favor of Acquiror;  and (iii) there is no Contract to which  Acquiror
is a party relating to the voting or registration  of, or restricting any Person
from purchasing,  selling,  pledging or otherwise  disposing of (or granting any
option or similar  right with respect to), any shares of Acquiror  Common Stock.
Acquiror  is not under any  obligation,  nor bound by any  Contract  pursuant to
which it may become  obligated,  to repurchase,  redeem or otherwise acquire any
outstanding shares of Acquiror Common Stock.

         3.4 SEC FILINGS; FINANCIAL STATEMENTS.

         (a) Acquiror has  delivered or made  available to the Company  accurate
and complete copies (excluding copies of exhibits) of each report,  registration
statement and definitive  proxy  statement  filed by Acquiror with the SEC since
January 1, 2000 and the date hereof,  together with any documents filed with the
SEC prior to the Effective Time (the "Acquiror SEC Documents").  All statements,
reports,  schedules,  forms and other  documents  required to have been filed by
Acquiror  with the SEC have been so filed on a timely  basis.  As of the time it
was filed with the SEC (or, if amended or  superseded  by a filing  prior to the
date of this Agreement,  then also on the date of such filing):  (i) each of the
Acquiror SEC Documents  complied in all material  respects  with the  applicable
requirements of the Securities Act or the Exchange Act (as the case may be); and
(ii) none of the  Acquiror SEC  Documents  contained  any untrue  statement of a
material fact or omitted to state a material fact required to be stated  therein
or  necessary  in order  to make the  statements  therein,  in the  light of the
circumstances  under which they were made,  not  misleading.  None of Acquiror's
Subsidiaries are required to file any reports or other documents with the SEC.

         (b) The consolidated financial statements contained in the Acquiror SEC
Documents:  (i) complied as to form in all material  respects with the published
rules and  regulations  of the SEC  applicable  thereto;  (ii) were  prepared in
accordance  with GAAP  applied on a  consistent  basis  throughout  the  periods
covered  (except as may be indicated in the notes to such  financial  statements
and, in the case of unaudited statements,  as permitted by Form 10-Q of the SEC,
and except that unaudited financial statements may not contain footnotes and are
subject to normal  and  recurring  year-end  audit  adjustments  which will not,
individually  or in the  aggregate,  be material in  amount);  and (iii)  fairly
present the consolidated  financial position of Acquiror and its subsidiaries as
of the respective  dates thereof and the  consolidated  results of operations of
Acquiror and its subsidiaries for the periods covered thereby.

         3.5 ABSENCE OF CERTAIN  CHANGES.  Between June 30, 2002 (the  "Acquiror
Balance Sheet Date") and the date hereof, Acquiror has conducted its business as
described  and proposed to be conducted in the Acquiror SEC  Documents and there
has not occurred:  (i) any change in accounting methods or practices  (including
any change in depreciation or amortization policies or rates) by Acquiror or any
revaluation by Acquiror of any of its assets  outside of the ordinary  course of
Acquiror's  business;  (ii) any  declaration,  setting  aside,  or  payment of a
dividend or other  distribution  with respect to the shares of Acquiror,  or any
direct or indirect redemption,  purchase or other acquisition by Acquiror of any
of its shares of capital stock,  other than  repurchases of stock as a result of
termination  of  employees;  (iii) any  agreement  by  Acquiror to do any of the
things  described in the preceding  clauses (i) through (ii); and (iv) except as
set forth in  Schedule  3.5(iv)  hereto,  between  [June 30,  2002] and the date
hereof  there  has not  occurred  any  event or  matter  which  caused  or could
reasonably be expected to cause any Material Adverse Effect.

                                       27


         3.6  ABSENCE  OF  UNDISCLOSED  LIABILITIES.  Acquiror  has no  material
obligations  or  liabilities  of any  nature  (matured  or  unmatured,  fixed or
contingent)  other than (i) those set forth or  adequately  provided  for in the
balance  sheet  included in the  financial  statements  contained  in the latest
Acquiror SEC Document;  (ii) those incurred in the ordinary course of Acquiror's
business as is  described  in and  proposed to be  conducted in the Acquiror SEC
Documents  since the  Acquiror  Balance  Sheet  Date;  (iii)  those  incurred in
connection with the execution and performance of this Agreement;  and (iv) those
incurred in the ordinary  course of  Acquiror's  business as is described in and
proposed to be  conducted  in the  Acquiror  SEC  Documents  since the  Acquiror
Balance  Sheet Date,  that,  in  accordance  with GAAP,  were not required to be
recorded thereon, and that, in the aggregate, are not material.

         3.7 LITIGATION.  Except as set forth in the Acquiror SEC Documents,  as
of the date hereof there is no Legal Proceeding  pending before any Governmental
Body or, to Acquiror's  Knowledge,  threatened,  against  Acquiror or any of its
properties or officers or directors (in their  capacities as such).  There is no
judgment,  decree or order against  Acquiror or any of its directors or officers
(in their capacities as such),  that could prevent,  enjoin, or materially alter
or delay any of the transactions  contemplated by this Agreement,  or that could
reasonably be expected to have a Material Adverse Effect on Acquiror.

         3.8 AUTHORITY; BINDING NATURE OF AGREEMENT.  Acquiror has all requisite
right, power and authority to perform its obligations under this Agreement.  The
execution,  delivery and performance by Acquiror of this Agreement has been duly
authorized  by all  necessary  action on the part of the board of  directors  of
Acquiror.  The board of  directors of Acquiror has  unanimously  authorized  and
approved the execution,  delivery and  performance of this Agreement by Acquiror
and  unanimously  approved  the Merger.  The  stockholders  of Acquiror  are not
required to approve this Agreement or the Merger. This Agreement constitutes the
legal,  valid and binding  obligation  of  Acquiror,  enforceable  against it in
accordance with its terms,  subject to (i) laws of general application  relating
to bankruptcy, insolvency, reorganization, moratorium and the relief of debtors,
and (ii) rules of law  governing  specific  performance,  injunctive  relief and
other equitable remedies.

         3.9  NON-CONTRAVENTION;  CONSENTS.  Except  as may be  required  by the
Securities Act, the Exchange Act, state securities or "blue sky" laws, the North
Carolina Business  Corporation Law, the HSR Act and any foreign antitrust law or
regulation, Acquiror is not, nor will it be, required to make any filing with or
give any notice to, or to obtain any Consent from, any Person in connection with
the execution, delivery or performance of this Agreement or any other agreements
referred to in this Agreement by Acquiror or the consummation by Acquiror of the
Merger  or any  other  transactions  contemplated  by this  Agreement.  Assuming
compliance  with the  foregoing,  then  except as  described  in Part 3.9 of the
Acquiror  Disclosure  Schedule,  neither  the  execution  and  delivery  of this
Agreement  by Acquiror nor the  consummation  by Acquiror of the Merger will (a)
contravene,  conflict  with or result  in any  breach  of any  provision  of the
articles of incorporation or bylaws of Acquiror or of any resolution  adopted by
the board of directors  or any  committee of the board of directors of Acquiror;
(b)  contravene,  conflict  with or  result  in a  violation  of,  or  give  any
Governmental  Body or other Person the right to  challenge  the Merger or any of
the other transactions  contemplated by this Agreement or to exercise any remedy
or  obtain  any  relief  under,  any  Legal  Requirement  or  any  order,  writ,
injunction,  judgment or decree to which Acquiror, or any of the assets owned or
used by  Acquiror,  is subject;  (c)  contravene,  conflict  with or result in a
violation  or breach  of, or result in a default  under,  any  provision  of any
material  Contract to which Acquiror is a party, or give any Person the right to
declare a default  or  exercise  any  remedy  under any such  Contract  to which


                                       28


Acquiror  is a party;  or (d) result in a  violation  by  Acquiror of any order,
writ, injunction, judgment or decree to which Acquiror is subject.

         3.10 FULL DISCLOSURE. This Agreement (including the Acquiror Disclosure
Schedule) does not, and the certificate  referred to in Section 7.3(b) will not,
(i)  contain  any  representation,  warranty  or  information  that is  false or
misleading with respect to any material fact, or (ii) omit to state any material
fact necessary in order to make the representations,  warranties and information
contained  and  to be  contained  herein  and  therein  (in  the  light  of  the
circumstances under which such representations,  warranties and information were
or will be made or provided) not false or misleading.

         3.11 VALID  ISSUANCE.  The  Acquiror  Common  Stock to be issued in the
Merger will, when issued in accordance with the provisions of this Agreement, be
validly issued, fully paid and nonassessable.

                                   SECTION 4
                  CERTAIN COVENANTS OF THE COMPANY AND ACQUIROR

         4.1 ACCESS AND  INVESTIGATION.  During  regular  business  hours in the
period from the date of this Agreement through the earlier of the termination of
this  Agreement or the Effective  Time (the  "Pre-Closing  Period"),  subject to
applicable   antitrust  laws  and  regulations   relating  to  the  exchange  of
information,  the  Company  shall,  and shall cause the  Representatives  of the
Company to: (i) provide Acquiror and Acquiror's  Representatives with reasonable
access  to  the  Company's  Representatives,  personnel  and  assets  and to all
existing  books,  records,  Tax  Returns,  work papers and other  documents  and
information  relating to the Company;  and (ii) provide  Acquiror and Acquiror's
Representatives  with such copies of the existing books,  records,  Tax Returns,
work papers and other  documents and  information  relating to the Company,  and
with  such  additional  financial,  operating  and  other  data and  information
regarding the Company, as Acquiror may reasonably request.  Without limiting the
generality  of the foregoing  but subject to the previous  sentence,  during the
Pre-Closing  Period,  the Company  shall (to the extent  requested  by Acquiror)
cause its officers to report regularly to Acquiror  concerning the status of the
Company's business and the Company shall as promptly as practicable after any of
the  following  reports,  materials,  communications,  notices or documents  are
prepared,  sent,  filed or received,  as the case may be, provide  Acquiror with
copies of: (A) all material  operating  and  financial  reports  prepared by the
Company for the Company's senior management;  (B) any material written materials
or communications  sent by or on behalf of the Company to its stockholders;  (C)
any notice, report or other document filed with or sent to any Governmental Body
in connection with the Merger or any of the other  transactions  contemplated by
this Agreement;  (D) any material notice,  report or other document  received by
the Company from any Governmental  Body; and (E) any of the foregoing related to
any Company Subsidiary.

         4.2 OPERATION OF THE COMPANY'S BUSINESS.

         (a)  Except  as set  forth in Part  4.2(a)  of the  Company  Disclosure
Schedule  and  as  otherwise  be  required  by  the  terms  hereof,  during  the
Pre-Closing  Period:  (i) the Company shall conduct its business and  operations
(A) in the ordinary  course and in  accordance  with past  practices  and (B) in
compliance with all applicable  Legal  Requirements  and the requirements of all
Company Contracts that constitute Material Contracts; (ii) the Company shall use
all commercially  reasonable efforts to ensure that the Company preserves intact
its current business  organization,  keeps available the services of its current


                                       29


officers and  employees  and  maintains  its  relations  and  goodwill  with all
suppliers,  customers, landlords, creditors, licensors, licensees, employees and
other Persons having business  relationships with the Company; (iii) the Company
shall maintain and keep its tangible  assets in good and safe  operating  order,
condition and repair,  ordinary wear and tear  excepted,  and shall keep in full
force all  insurance  policies  and  fiduciary  bonds;  (iv) the  Company  shall
maintain and preserve its unencumbered  right to use each Proprietary Asset; and
(v) the  Company  shall  promptly  notify  Acquiror  of (A) any  notice or other
communication from any Person alleging that the Consent of such Person is or may
be required in connection with the transactions  contemplated by this Agreement,
and (B) any Legal Proceedings commenced or, to its Knowledge threatened against,
relating to or involving or otherwise  affecting the Company which relate to the
consummation of the transactions contemplated by this Agreement.

         (b)  Except  as set  forth in Part  4.2(b)  of the  Company  Disclosure
Schedule,  during the  Pre-Closing  Period,  the Company  shall not (without the
prior written consent of Acquiror):

               (i)  declare,  accrue,  set aside or pay any dividend or make any
          other  distribution  in respect of any  shares of  capital  stock,  or
          repurchase,  redeem or otherwise reacquire any shares of capital stock
          or other securities other than pursuant to Company  repurchase  rights
          in connection with the termination of an employee;

               (ii) sell, issue, grant or authorize the issuance or grant of (A)
          any capital stock or other security  except upon the valid exercise of
          outstanding Company Options, (B) any option, call, warrant or right to
          acquire any capital stock or other security except for Company Options
          granted  in the  ordinary  course  of  business  consistent  with past
          practices,  or (C) any instrument convertible into or exchangeable for
          any capital stock or other security;

               (iii) amend or waive any of its rights under,  or accelerate  the
          vesting under,  any provision of the Company's  stock option plan, any
          provision of any agreement  evidencing any outstanding stock option or
          any restricted  stock purchase  agreement,  or otherwise modify any of
          the terms of any outstanding option,  warrant or other security or any
          related Contract except as contemplated hereby;

               (iv)  except as  expressly  contemplated  by the Proxy and Voting
          Agreements,  amend or permit  the  adoption  of any  amendment  to its
          certificate of incorporation or bylaws, or effect or become a party to
          any  merger,  consolidation,  share  exchange,  business  combination,
          recapitalization,  reclassification  of shares,  stock split,  reverse
          stock split or similar transaction;

               (v) make any  capital  expenditure  (except  that the Company may
          make  capital  expenditures  that,  when  added to all  other  capital
          expenditures  made on behalf of the  Company  during  the  Pre-Closing
          Period, do not exceed $100,000 in the aggregate);

               (vi) other than in the ordinary course of business, enter into or
          become  bound by, or permit any of the  assets  owned or used by it to
          become  bound by, any Material  Contract,  or amend or  terminate,  or
          waive or exercise any  material  right or remedy  under,  any Material
          Contract;

               (vii) acquire, lease or license any right or other asset from any
          other  Person or sell or  otherwise  dispose  of, or pledge,  lease or
          license,  any right or other asset to any other Person (except in each
          case for assets  acquired,  leased,  licensed  or  disposed  of by the
          Company in the ordinary  course of business and  consistent  with past
          practices), acquire any equity interest or other interest in any other
          Entity or waive or relinquish any material right;

                                       30


               (viii) lend money to any Person  except for employee  advances in
          the  ordinary   course  of  business,   or  incur  or  guarantee   any
          indebtedness;

               (ix) other than in the ordinary  course of  business,  establish,
          adopt or amend any employee  benefit  plan,  pay any bonus or make any
          profit-sharing  or similar  payment to, or increase  the amount of the
          wages, salary,  commissions,  fringe benefits or other compensation or
          remuneration payable to, any of its directors, officers or employees;

               (x) take or permit to be taken any action  that  could  cause the
          Merger not to constitute a reorganization  under Section 368(a) of the
          Code;

               (xi) make any  material  Tax  election  or change any  methods of
          accounting or accounting practices in any material respect;

               (xii) (A)  commence  or  become a party to any  Legal  Proceeding
          (except  for  routine  collection  matters)  or (B)  settle  any Legal
          Proceeding which in the case of (A) or (B), in the reasonable judgment
          of  Acquiror,  there is a  reasonable  possibility  of an outcome that
          could have a Material  Adverse Effect on the Company or materially and
          adversely affect Acquiror.

               (xiii)  enter  into any  material  transaction  or take any other
          material   action   outside  the   ordinary   course  of  business  or
          inconsistent with past practices;

               (xiv) enter into any Contract with an Affiliate; or

               (xv)  agree or commit  to take any of the  actions  described  in
          clauses "(i)" through "(xiv)" of this Section 4.2(b).

         (c) During the  Pre-Closing  Period,  the Company shall promptly notify
Acquiror  in  writing  of:  (i)  the  discovery  by the  Company  of any  event,
condition, fact or circumstance that occurred or existed on or prior to the date
of this  Agreement and that caused or  constitutes a material  inaccuracy in any
representation  or warranty made by the Company in this  Agreement such that the
conditions  specified in Section 6.1 would not be satisfied;  (ii) the discovery
by the Company of any event, condition, fact or circumstance that occurs, arises
or exists after the date of this  Agreement and that would cause or constitute a
material  inaccuracy  in any  representation  or warranty made by the Company in
this  Agreement if (A) such  representation  or warranty had been made as of the
time of the occurrence, existence or discovery of such event, condition, fact or
circumstance,  or (B) such event, condition,  fact or circumstance had occurred,
arisen or existed on or prior to the date of this Agreement;  (iii) any material
breach  of any  covenant  or  obligation  of the  Company;  and (iv) any  event,
condition,  fact or circumstance that would make the timely  satisfaction of any
of the  conditions set forth in Section 6 impossible or unlikely or that has had
or could  reasonably  be  expected  to have a  Material  Adverse  Effect  on the
Company.  Without  limiting the generality of the  foregoing,  the Company shall
promptly advise Acquiror in writing of any material Legal Proceeding or material
claim threatened,  commenced or asserted against or with respect to the Company.
No notification given to Acquiror pursuant to this Section 4.2(c) shall limit or


                                       31


otherwise  affect  any  of  the   representations,   warranties,   covenants  or
obligations of the Company contained in this Agreement.

         (d) Except to the extent the context otherwise  requires,  "Company" as
used in this  Section  4.2 shall be deemed to mean each of the  Company and each
Company Subsidiary individually (and not collectively or in the aggregate).

         4.3 OPERATION OF ACQUIROR'S BUSINESS.

         (a) During the  Pre-Closing  Period,  Acquiror  shall not  (without the
prior written consent of the Company):

               (i)  conduct  its  business  and  operations  other  than  in the
          ordinary course and in compliance with all Legal Requirements;

               (ii) take or permit to be taken any action that could  reasonably
          be expected to materially delay the consummation of the Merger;

               (iii) declare,  accrue, set aside or pay any dividend or make any
          other distribution in respect of any shares of capital stock;

               (iv)  repurchase,  redeem or  otherwise  reacquire  any shares of
          capital  stock in any case in exchange for shares of Acquiror  capital
          stock;

               (v)  agree or  commit  to take any of the  actions  described  in
          clauses "(i)" through "(iv)" of this Section 4.3(a); or

               (vi) take or permit to be taken any action  that could  cause the
          Merger not to constitute a reorganization  under Section 368(a) of the
          Code.

         (b) During the Pre-Closing  Period,  Acquiror shall promptly notify the
Company in writing of: (i) the  discovery  by Acquiror of any event,  condition,
fact or  circumstance  that  occurred or existed on or prior to the date of this
Agreement  and  that  caused  or  constitutes  a  material   inaccuracy  in  any
representation  or warranty made by Acquiror in this Agreement;  (ii) any event,
condition,  fact or circumstance that occurs, arises or exists after the date of
this  Agreement and that would cause or constitute a material  inaccuracy in any
representation  or  warranty  made by  Acquiror  in this  Agreement  if (A) such
representation  or  warranty  had been  made as of the  time of the  occurrence,
existence or discovery of such event,  condition,  fact or circumstance,  or (B)
such event, condition,  fact or circumstance had occurred,  arisen or existed on
or  prior  to the date of this  Agreement;  (iii)  any  material  breach  of any
covenant or  obligation  of  Acquiror;  and (iv) any event,  condition,  fact or
circumstance  that would make the timely  satisfaction  of any of the conditions
set forth in Section 7 impossible  or  unlikely.  No  notification  given to the
Company  pursuant to this Section 4.3(b) shall limit or otherwise  affect any of
the representations,  warranties, covenants or obligations of Acquiror contained
in this Agreement.

                                       32


         4.4 NO SOLICITATION.

         (a) The  Company  shall  not  directly  or  indirectly,  and  shall not
authorize or permit any Representative of the Company directly or indirectly to,
(i) solicit,  initiate,  knowingly  encourage,  induce or facilitate the making,
submission or announcement  of any Acquisition  Proposal or take any action that
could  reasonably be expected to lead to an Acquisition  Proposal,  (ii) furnish
any  information  regarding the Company to any Person in  connection  with or in
response to an Acquisition Proposal or an inquiry or indication of interest that
could  lead  to  an  Acquisition  Proposal,   (iii)  engage  in  discussions  or
negotiations  with any Person with  respect to any  Acquisition  Proposal,  (iv)
approve,  endorse or recommend  any  Acquisition  Proposal or (v) enter into any
letter of intent or similar document or any Contract  contemplating or otherwise
relating to any Acquisition Transaction.

         (b) The Company shall promptly advise Acquiror orally and in writing of
any  Acquisition  Proposal,  any inquiry or  indication  of interest  that could
reasonably  lead  to an  Acquisition  Proposal  or  any  request  for  nonpublic
information relating to the Company from a Person who would reasonably be likely
to make an Acquisition  Proposal (including the identity of the Person making or
submitting  such  Acquisition  Proposal,  inquiry,  indication  of  interest  or
request, and the relevant terms thereof) that is made or submitted by any Person
during the  Pre-Closing  Period.  The Company shall keep Acquiror fully informed
with respect to the status of any such Acquisition Proposal, inquiry, indication
of interest or request and any modification or proposed modification thereto.

         (c) The Company shall  immediately cease and cause to be terminated any
existing discussions with any Person that relate to any Acquisition Proposal.

                                   SECTION 5
                       ADDITIONAL COVENANTS OF THE PARTIES

         5.1  ACTION  BY  CERTAIN  COMPANY  STOCKHOLDERS.  Concurrent  with  the
execution of this Agreement,  (a) each of the individuals  listed in Part 5.1(a)
of the Company  Disclosure  Schedule  have  executed and delivered to Acquiror a
Proxy and Voting  Agreement in a form prescribed by Acquiror and (b) each of the
individuals  listed  in Part  5.1(b) of the  Company  Disclosure  Schedule  have
executed and delivered to Acquiror an Employment  Agreement in a form prescribed
by Acquiror.

         5.2  REGULATORY  APPROVALS.  The  Company  and  Acquiror  shall use all
commercially  reasonable  efforts to file, as soon as practicable after the date
of this Agreement, all notices, reports and other documents required to be filed
with any Governmental Body with respect to the Merger and the other transactions
contemplated  by  this   Agreement,   and  to  submit  promptly  any  additional
information   requested  by  any  such  Governmental  Body,   including  without
limitation in connection with the provisions of the HSR Act (the "HSR Filings").
Acquiror shall be solely  responsible for the payment of any filing fees payable
to a Governmental Body in connection with the HSR Filings.

         5.3 STOCK OPTIONS.

         (a) Subject to Section  5.3(b),  at the Effective Time, all rights with
respect to Company  Common  Stock under each  Company  Option then  outstanding,
whether vested or unvested, shall be converted into and become rights to acquire
Acquiror  Common Stock,  and Acquiror  shall assume each such Company  Option in
accordance with  substantially the same terms and conditions (as in effect as of
the date of this  Agreement)  of the stock option plan under which it was issued
and the same terms and  conditions of the stock option  agreement by which it is


                                       33


evidenced,  subject to any amendments  deemed necessary or advisable by Acquiror
in order  to  comply  with  applicable  Legal  Requirements  (including  without
limitation  the  Securities  Act and the  Exchange  Act).  From  and  after  the
Effective  Time,  (i) each Company  Option  assumed by Acquiror may be exercised
solely  for  shares  of  Acquiror  Common  Stock,  (ii) the  number of shares of
Acquiror  Common Stock subject to each such Company Option shall be equal to the
number of  shares  of  Company  Common  Stock  subject  to such  Company  Option
immediately prior to the Effective Time multiplied by a fraction,  the numerator
of which is the Common  Allocation of Acquiror  Stock,  and the  denominator  of
which is the Diluted  Company  Common  Shares,  rounding the product down to the
nearest whole share,  (iii) the per share exercise price under each such Company
Option  shall be adjusted by dividing  the per share  exercise  price under such
Company Option immediately prior to the Effective Time by the fraction set forth
in Section  5.3(a)(ii)  above,  and rounding the product up to the nearest cent,
(iv) any  restriction  on the exercise of any such Company Option shall continue
in full force and  effect and the term,  exercisability,  vesting  schedule  and
other provisions of such Company Option and shares acquired upon exercise of any
Company  Option shall  otherwise  remain  unchanged  except as set forth in this
Section  5.3(a)  or in such  Plan or  agreement;  provided,  however,  that each
Company Option assumed by Acquiror in accordance with this Section 5.3(a) shall,
in accordance with its terms, be subject to further adjustment as appropriate to
reflect any stock split, stock dividend, reverse stock split,  reclassification,
recapitalization or other similar transaction  subsequent to the Effective Time.
Notwithstanding  the  foregoing,  each Company  Option that is intended to be an
"incentive  stock  option"  (as  defined  in Section  422 of the Code)  shall be
adjusted in accordance with the  requirements of Section 424 of the Code and the
Regulations  promulgated  thereunder  so as to  continue as an  incentive  stock
option  under  Section  424  of  the  Code,  and  so  as  not  to  constitute  a
modification,  extension or removal of the option  within the meaning of Section
424(h) of the Code. It is the intention of the parties that the Company  Options
assumed by Acquiror  qualify,  to the maximum extent  permissible  following the
Effective  Time,  as  incentive  stock  options as defined in Section 422 of the
Code,  to the extent the Company  Options  qualified as incentive  stock options
immediately  prior  to the  Effective  Time.  As soon  as  practical  after  the
Effective  Time but in no event  more  than 15 days  after the  Effective  Time,
Acquiror shall file with the SEC a  registration  statement on Form S-8 relating
to the shares of Acquiror  Common  Stock that are  issuable  with respect to the
Company  Options  assumed by Acquiror in accordance with this Section 5.3(a) and
that are eligible for  registration  on such Form. To the extent such shares are
not eligible for registration on Form S-8, but are eligible for inclusion in the
registration referred to in Section 5.9, such shares shall be included therein.

         (b) Prior to the Effective Time, the Company shall take all action that
may be  necessary  (under  the  plans  pursuant  to which  Company  Options  are
outstanding  and  otherwise) or may be requested by Acquiror to  effectuate  the
provisions of this Section 5.3 and to ensure that,  from and after the Effective
Time,  holders of Company Options have no rights with respect thereto other than
those specifically provided in this Section 5.3.

         5.4 EMPLOYEE BENEFITS.

         (a)  Acquiror  agrees that all  employees  of the Company who  continue
employment with Acquiror or the Surviving  Corporation  after the Effective Time
("Continuing  Employees")  shall  be  eligible  to  participate  in the  health,
vacation and other  non-equity  based employee benefit plans of Acquiror and its
affiliates (each an "Acquiror Plan" and collectively,  the "Acquiror Plans"), to
substantially  the same extent as employees of Acquiror in similar positions and


                                       34


at similar grade levels without  regard to any  preexisting  condition,  waiting
period or other restriction that may delay the Continuing  Employees'  immediate
participation  in the Acquiror Plans;  provided,  however,  that nothing in this
Section 5.4(a) or elsewhere in this Agreement  shall limit the right of Acquiror
to amend or terminate any such Acquiror Plans at any time. Acquiror shall credit
Continuing  Employee's  service  with the  Company  to the same  extent  as such
service was or would have been credited under the similar employee benefit plans
of the  Company  immediately  prior  to the  Effective  Time,  for  purposes  of
determining eligibility to participate in and vesting under such Acquiror Plans,
but not for  purposes  of benefit  accrual  under any  defined  benefit  plan of
Acquiror.

         (b) Nothing in this Section 5.4 or elsewhere in this Agreement shall be
construed to create a right in any employee to  employment  with Acquiror or any
Subsidiary of Acquiror and,  subject to any other binding  agreement  between an
employee and Acquiror or any  Subsidiary  of Acquiror,  the  employment  of each
Continuing Employee shall be "at will" employment.

         5.5 ADDITIONAL AGREEMENTS.

         (a) Subject to Section  5.5(b),  Acquiror and the Company shall use all
commercially  reasonable  efforts  to take,  or cause to be taken,  all  actions
necessary to consummate  the Merger and make  effective  the other  transactions
contemplated  by  this  Agreement.   Without  limiting  the  generality  of  the
foregoing, but subject to Section 5.5(b), each party to this Agreement (i) shall
make all filings (if any) and give all notices (if any)  required to be made and
given by such party in  connection  with the  Merger and the other  transactions
contemplated  by this  Agreement,  (ii)  shall use all  commercially  reasonable
efforts to obtain each Consent (if any) required to be obtained (pursuant to any
applicable  Legal  Requirement  or  Contract,  or  otherwise)  by such  party in
connection with the Merger or any of the other transactions contemplated by this
Agreement;  provided,  however,  that  except  for  filing  fees  payable to any
Governmental  Body as  generally  provided  in Section  5.2,  no party  shall be
required  to pay any  material  consideration  in order to obtain  any  required
Consent,  and (iii) shall use all  commercially  reasonable  efforts to lift any
restraint,  injunction  or other  legal  bar to the  Merger so long as the other
party is doing the same. The Company shall  promptly  deliver to Acquiror a copy
of each such filing made, each such notice given and each such Consent  obtained
by the Company during the Pre-Closing Period. Acquiror shall promptly deliver to
the Company a copy of each such  filing  made,  each such notice  given and each
such  Consent  obtained  by  Acquiror  during the  Pre-Closing  Period.  Nothing
contained in this Section 5.5(a) or elsewhere in this Agreement  shall limit the
obligation  of the  Company  to obtain  Acquiror's  consent to the taking of any
action that would otherwise give rise to a violation of Section 4.2.

         (b)  Notwithstanding   anything  to  the  contrary  contained  in  this
Agreement,  Acquiror shall not have any obligation under this Agreement:  (i) to
dispose or transfer or cause any of its  Subsidiaries  to dispose of or transfer
any assets, or to commit to cause the Company to dispose of any assets;  (ii) to
discontinue or cause any of its Subsidiaries to discontinue offering any product
or  service,  or to commit to cause the  Company  to  discontinue  offering  any
product or service;  (iii) to license or otherwise make available,  or cause any
of its Subsidiaries to license or otherwise make available,  to any Person,  any
technology  or other  Proprietary  Asset,  or to commit to cause the  Company to
license or  otherwise  make  available  to any Person  any  technology  or other
Proprietary  Asset  other than  pursuant to  Contracts  set forth in the Company
Disclosure  Schedule;  (iv) to hold separate or cause any of its Subsidiaries to
hold  separate  any assets or  operations  (either  before or after the  Closing
Date),  or to  commit  to cause  the  Company  to hold  separate  any  assets or
operations other than pursuant to Contracts set forth in the Company  Disclosure


                                       35


Schedule;  (v) to make or cause any of its  Subsidiaries  to make any commitment
(to any Governmental  Body or otherwise)  regarding its future operations or the
future  operations  of the  Company;  or (vi) to  contest  any Legal  Proceeding
relating to the Merger if Acquiror determines in good faith that contesting such
Legal Proceeding would not be advisable.

         5.6 DISCLOSURE.

         (a)  The  Company   shall  not,   and  shall  not  permit  any  of  its
Representatives  to, issue any press release or otherwise  publicly  disseminate
any  document  or other  written  material  relating to the Merger or any of the
other transactions contemplated by this Agreement unless (i) Acquiror shall have
approved such press release or written material,  such approval to be granted or
withheld in  Acquiror's  sole  discretion,  or (ii) the Company  shall have been
advised by its outside  legal counsel that the issuance of such press release or
the  dissemination of such written material is required by any applicable law or
regulation,  and the Company shall have consulted with Acquiror prior to issuing
such press release or disseminating such written material. The Company shall use
all  reasonable  efforts to ensure  that none of its  Representatives  makes any
public statement that is materially  inconsistent  with any press release issued
or any written material publicly disseminated by the Company with respect to the
Merger or with  respect to any of the other  transactions  contemplated  by this
Agreement.

         (b)  Acquiror  shall  not,  and  shall  not  permit  any of  Acquiror's
Representatives  to, issue any press release or otherwise  publicly  disseminate
any  document  or other  written  material  relating to the Merger or any of the
other  transactions  contemplated by this Agreement unless (i) the Company shall
have approved such press release or written  material (it being  understood that
the  Company  shall not  unreasonably  withhold  its  approval of any such press
release or written  material),  or (ii) Acquiror  shall have been advised by its
outside   legal  counsel  that  the  issuance  of  such  press  release  or  the
dissemination  of such  written  material is required by any  applicable  law or
regulation,  and Acquiror shall have consulted with the Company prior to issuing
such press release or disseminating  such written  material.  Acquiror shall use
all commercially  reasonable efforts to ensure that none of its  Representatives
makes  any  public  statement  that is  materially  inconsistent  with any press
release issued or any written  material  publicly  disseminated by Acquiror with
respect  to the  Merger  or  with  respect  to any  of  the  other  transactions
contemplated by this Agreement.

         5.7 TAX REPRESENTATION LETTERS. At or prior to the Closing, the Company
and Acquiror shall execute and deliver to Ernst & Young, LLP tax  representation
letters in customary form. Such parties shall each confirm to Ernst & Young, LLP
the accuracy and completeness as of the Effective Time of the tax representation
letters delivered pursuant to the immediately preceding sentence.

         5.8 TERMINATION OF AGREEMENTS.  The Company shall use all  commercially
reasonable  efforts to obtain and deliver to  Acquiror  at the  Closing  written
termination of:

         (a) that certain Third Amended and Restated  Investor Rights Agreement,
dated June 6, 2002, by and among Resonext Communications,  Inc., the Holders and
the Founders, as each such terms are defined therein

         (b) that certain  Series A Preferred  Stock Purchase  Agreement,  dated
December 22, 1999;

         (c) that certain  Series B Preferred  Stock Purchase  Agreement,  dated
November 1, 2000;

                                       36


         (d) that certain  Series C Preferred  Stock Purchase  Agreement,  dated
June 6, 2002; and

         (e) the Company's 1999 Stock Bonus Plan.

         5.9 REGISTRATION EXEMPTION; FAIRNESS HEARING.

         (a) As soon as practicable  after the parties  execute this  Agreement,
but in any event not later than ten business days after the parties execute this
Agreement, Acquiror will file a request for a hearing (the "Hearing") before the
North Carolina  Secretary of State or the California  Department of Corporations
to consider the terms, conditions, and fairness of the transactions contemplated
by this  Agreement  pursuant  to Section  78A-30 of the North  Carolina  General
Statutes, as amended, or Section 25142 of the GCLC, as applicable, together with
an application for approval  relating to the  transactions  contemplated by this
Agreement (the "Permit"). The Company and Acquiror will promptly furnish to each
other all data and  information  relating  to such party as may be  required  in
connection  with  such  request  and  application  and such  other  notices  and
documents as may be required in  connection  with the Hearing.  Acquiror and the
Company will use their respective  commercially  reasonable efforts to cause the
Hearing to take place and the  Permit to be issued at the  earliest  practicable
date.  Upon receiving the Permit,  the Company will as promptly as  practicable,
submit this Agreement and the  transactions  contemplated  by this Agreement for
approval  and  adoption by the Company  Stockholders.  The Company  will use its
commercially reasonable efforts to solicit and receive the Requisite Stockholder
Approval, which, if in the form of written consents, shall be acceptable in form
and substance to Acquiror.

         (b) Acquiror will prepare and file with appropriate state securities or
"Blue Sky"  authorities  all  applications  for  qualification  or approval  (or
notices required to perfect  exemptions from such compliance) as may be required
in  connection  with the Merger.  The Company will use  commercially  reasonable
efforts to assist  Acquiror as may be  reasonably  necessary  to comply with all
appropriate  state  securities  or Blue  Sky  laws  that  may be  applicable  in
connection with the Merger.

         (c) In  connection  with the  Hearing,  the parties  will  cooperate in
preparing  an   information   statement   describing   this  Agreement  and  the
transactions  contemplated  by this  Agreement for the purpose of soliciting the
Requisite  Stockholder Approval (the "Information  Statement").  The Information
Statement will describe the Merger Consideration  payable pursuant to Section 1.
The Company  hereby  represents  and warrants to Acquiror  that the  information
supplied by the Company for inclusion in the Information  Statement will not, on
the  date  that  the  Information  Statement  is  first  mailed  to the  Company
Stockholders or at the Effective Time, contain any statement that, at such time,
is false or misleading  with respect to any material  fact, or omit to state any
material fact necessary in order to make the statements  made therein,  in light
of the circumstances under which they are made, not misleading, or omit to state
any  material   fact   necessary  to  correct  any   statement  in  any  earlier
communication  that  has  become  false  or  misleading.   Notwithstanding   the
foregoing,  the Company  makes no  representation,  warranty,  or covenant  with
respect to any information  supplied by Acquiror that is contained in any of the
foregoing documents. Acquiror hereby represents and warrants to the Company that
the information supplied by Acquiror for inclusion in the Information  Statement
will not,  on the date that the  Information  Statement  is first  mailed to the
Company Stockholders,  nor at the Effective Time, contain any statement that, at
such time, is false or misleading  with respect to any material fact, or omit to
state any material fact  necessary in order to make the statements  therein,  in


                                       37


light of the  circumstances  under which it is made,  not false or misleading or
omit to state any  material  fact  necessary  to correct  any  statement  in any
earlier  communication that has become false or misleading.  Notwithstanding the
foregoing, Acquiror makes no representation,  warranty, or covenant with respect
to any  information  supplied by the  Company  that is  contained  in any of the
foregoing documents.

         (d) The Information Statement will constitute a disclosure document for
the offer and issuance of shares of Acquiror  Common Stock to be received by the
holders of the Company  Stock in the Merger.  Acquiror and the Company will each
use commercially reasonable efforts to cause the Information Statement to comply
in all material  respects  with  applicable  federal and state  securities  laws
requirements.  Each of Acquiror and the Company agree to provide promptly to the
other such  information  concerning  its business and financial  statements  and
affairs  as,  in the  reasonable  judgment  of a party  or its  counsel,  may be
required or  appropriate  for inclusion in the  Information  Statement or in any
amendments  or  supplements  thereto,  and to cause its counsel and  auditors to
cooperate  with the other's  counsel  and  auditors  in the  preparation  of the
Information  Statement.  The Company will promptly advise Acquiror, and Acquiror
will  promptly  advise  the  Company,  in  writing,  if at any time  before  the
Effective  Time,  either the Company or Acquiror  learns of any facts that might
make it  necessary  or  appropriate  to  amend  or  supplement  the  Information
Statement in order to make the statements contained or incorporated by reference
therein  not  misleading  or to  comply  with  applicable  Law.  Notwithstanding
anything to the contrary contained in this Section 5.9, neither the Acquiror nor
the Company will  include in the  Information  Statement  any  information  with
respect  to the other  Party or the  other  Party's  Affiliates  if the form and
content of such  information  has not been  approved by such other Party  before
such inclusion.

         (e)  Acquiror  and the Company  intend that the  Acquiror  Common Stock
issued in the Merger,  if any,  will be issued  pursuant to the  exemption  from
registration  under  Securities Act Section  3(a)(10).  Acquiror and the Company
agree to take, or to refrain from taking,  any action as necessary to ensure the
availability of such Section 3(a)(10) exemption.

         (f)  In  the  event  Acquiror  shall  not  have  received  a  favorable
determination in the Fairness Hearing and a Permit covering all of the shares of
Acquiror  Common  Stock to be  issued  in the  Merger  such  that  the  issuance
qualifies for exemption under the 3(a)(10) exemption,  the Closing of the Merger
and the other transactions  contemplated by this Agreement shall, subject to the
satisfaction  or  waiver  of the other  conditions  set  forth in  Section 6 and
Section 7 below,  take place as provided in Section 1 hereof,  provided that the
shares  of  Acquiror  Common  Stock to be  issued  to the  Company  Stockholders
hereunder shall be registered on Form S-4 as set forth in Section 5.9(g) below.

         (g) As promptly as practicable  after an unfavorable  determination  in
the Fairness  Hearing,  the Company and Acquiror shall prepare and file with the
SEC, a Proxy Statement/Prospectus,  and Acquiror shall prepare and file with the
SEC a registration  statement covering the shares of Acquiror Common Stock to be
issued in the Merger  pursuant  to Section 1.5 hereof on Form S-4 (the "S-4") in
which the Proxy Statement/Prospectus shall be included as a prospectus.  Each of
Acquiror and the Company  shall provide  promptly to the other such  information
concerning  its  business  and  financial  statements  and  affairs  as,  in the
reasonable  judgment of the providing  party or its counsel,  may be required or
appropriate for inclusion in the Proxy  Statement/Prospectus  and the S-4, or in
any amendments or supplements  thereto, and to cause its counsel and auditors to
cooperate with the other's  counsel and auditors in the preparation of the Proxy
Statement/Prospectus and the S-4. In this connection, the parties will be deemed
to make the same  representations  and  warranties to one another  regarding the


                                       38


Proxy  Statement/Prospectus as they hereby make in Section 5.9(c) above, subject
to the same  limitations.  Each of the Company and Acquiror shall respond to any
comments  of the SEC,  and  shall  use its  respective  commercially  reasonable
efforts to have the S-4 declared  effective under the Securities Act as promptly
as  practicable  after  such  filing,  and the  Company  shall  cause  the Proxy
Statement/Prospectus   to  be  mailed  to  its   stockholders  at  the  earliest
practicable time after the S-4 is declared  effective by the SEC. As promptly as
practicable  after the date of this Agreement,  each of the Company and Acquiror
shall  prepare and file any other  filings  required to be filed by it under the
Exchange Act, the Securities  Act or any other  Federal,  foreign or Blue Sky or
related laws relating to the Merger and the  transactions  contemplated  by this
Agreement (the "Other  Filings").  Each of the Company and Acquiror shall notify
the other promptly upon the receipt of any comments from the SEC or its staff or
any other government officials and of any request by the SEC or its staff or any
other  government  officials for amendments or supplements to the S-4, the Proxy
Statement/Prospectus or any Other Filing or for additional information and shall
supply the other with copies of all correspondence  between such party or any of
its  representatives,  on the one  hand,  and the SEC or its  staff or any other
government  officials,  on the other hand,  with  respect to the S-4,  the Proxy
Statement/Prospectus,  the Merger or any Other  Filing.  Each of the Company and
Acquiror shall cause all documents  that it is  responsible  for filing with the
SEC or other regulatory  authorities  under this Section 5.9(g) to comply in all
material  respects  with all  applicable  requirements  of law and the rules and
regulations promulgated thereunder.  Whenever any event occurs which is required
to be set forth in an amendment or supplement to the Proxy Statement/Prospectus,
the S-4 or any other Filing, the Company or Acquiror,  as the case may be, shall
promptly  inform the other of such  occurrence  and cooperate in filing with the
SEC  or  its  staff  or  any  other  government  officials,  and/or  mailing  to
stockholders of the Company, such amendment or supplement.

         5.10 COMPANY STOCKHOLDERS' MEETING.

         (a) The Company shall take all action  necessary  under all  applicable
Legal  Requirements to call, give notice of and hold a meeting of the holders of
Company  Common  Stock  and  Company  Preferred  Stock to obtain  the  Requisite
Stockholder Approval (the "Company Stockholders' Meeting"). In lieu of a Company
Stockholders'  Meeting,  the  Company  may  circulate  a written  consent of its
stockholders   in  conformity  with  applicable  law  to  obtain  the  Requisite
Stockholder Approval. The Company Stockholders' Meeting shall be held (on a date
selected  by  the  Company  in  consultation   with  Acquiror)  as  promptly  as
practicable  after receipt of notice from the North Carolina  Secretary of State
or California  Department of Corporations  approving the issuance by Acquiror of
Acquiror  Common  Stock  to the  Company  Stockholders  or the  date  the S-4 is
declared  effective  by the SEC.  The  Company  shall  ensure  that all  proxies
solicited in connection with the Company  Stockholders' Meeting are solicited in
compliance with all applicable Legal Requirements.

         (b) The  Information  Statement or Proxy  Statement/Prospectus,  as the
case may be,  shall  include a  statement  to the effect that the members of the
board of directors of the Company who were present at the meeting referred to in
Section 2.4 hereof unanimously  recommends that the Company Stockholders vote to
approve the principal terms of the Merger at the Company  Stockholders'  Meeting
(the  recommendation  of the  Company's  board of directors  that the  Company's
stockholders vote to approve the principal terms of the Merger being referred to
as the "Company Board  Recommendation").  The Company Board Recommendation shall
not be withdrawn or modified in a manner adverse to Acquiror,  and no resolution
by the board of directors of the Company or any committee thereof to withdraw or


                                       39


modify the Company Board Recommendation in a manner adverse to Acquiror shall be
adopted or proposed.

         5.11  AFFILIATE  AGREEMENTS.  The  Company  shall use all  commercially
reasonable  efforts to cause each  Person who is or becomes (or may be deemed to
be) an  "affiliate"  (as that term is defined  in Rule 145 under the  Securities
Act) of the Company to execute and deliver to Acquiror, prior to the date of the
mailing  of the  Information  Statement  or  Proxy  Statement/Prospectus  to the
Stockholders,  an Affiliate Agreement in the form of Exhibit E. Neither Acquiror
nor the Company shall register,  or allow its transfer agent to register, on its
books any transfer of any shares of Acquiror Common Stock,  Company Common Stock
or  Company  Preferred  Stock  of any  "affiliate"  of the  Company  who has not
provided a signed Affiliate Agreement in accordance with this Section 5.11.

         5.12 LETTER OF THE COMPANY'S  ACCOUNTANTS.  If applicable,  the Company
shall  use all  commercially  reasonable  efforts  to cause to be  delivered  to
Acquiror a letter of Ernst & Young,  LLP,  dated no more than two business  days
before the date on which the Form S-4 Registration  Statement  becomes effective
(and  reasonably  satisfactory  in form  and  substance  to  Acquiror),  that is
customary in scope and substance  for letters  delivered by  independent  public
accountants in connection with registration  statements  similar to the Form S-4
Registration Statement.

         5.13  CONFIDENTIALITY.  The provisions of that certain  Confidentiality
Agreement   dated   September  18,  2002  between   Acquiror  and  Company  (the
"Confidentiality  Agreement")  shall  apply to any  information  transmitted  or
disclosed by any Party hereunder;  provided,  that to the extent of any conflict
between the terms of this Agreement and the Confidentiality Agreement, the terms
hereof shall  control and the terms of the  Confidentiality  Agreement  shall be
deemed conformed hereto.

         5.14 TAX-FREE  REORGANIZATION.  The parties to this Agreement shall not
take any action prior to, on or after the Effective  Time that would  reasonably
be  expected to cause the Merger to fail to qualify as a  reorganization  within
the meaning of Section  368(a) of the Code.  Acquiror and the Company  shall use
all  commercially  reasonable  efforts prior to the Effective  Time to cause the
Merger to qualify as a  reorganization  under  Section  368(a) of the Code.  The
parties  hereto  shall  comply  with  the  reporting  requirements  of  Treasury
Regulation Section 1.368-3.

         5.15 NO UNDUE DELAY.  The parties to this Agreement  shall not take any
action that would reasonably be expected to cause the Closing to occur after the
End Date.

         5.16 DIRECTORS AND OFFICERS  PROTECTION.  Acquiror or any Subsidiary of
Acquiror  shall  provide  and keep in force for a period of six years  after the
Effective Time directors' and officers'  liability  insurance providing coverage
to the directors and officers of the Company  immediately prior to the Effective
Time for acts or omissions occurring prior to the Effective Time. Such insurance
shall  provide  at least the same  coverage  and  amounts  as  contained  in the
Company's policy on the date hereof; provided, that in no event shall the annual
premium on such policy exceed $50,000 (the "Maximum  Amount").  If the amount of
the premiums  necessary to maintain or procure such insurance  coverage  exceeds
the Maximum  Amount,  Acquiror shall use its reasonable  efforts to maintain the
most  advantageous  policies of  directors'  and officers'  liability  insurance
obtainable for a premium equal to the Maximum Amount. Acquiror further agrees to
indemnify  (including  the  advancement  of expenses to the extent  permitted by
Acquiror  under its  officer  and  director  indemnification  procedures)  those
individuals who were officers or directors of the Company  immediately  prior to
the Effective  Time from any acts or omissions in such  capacities  prior to the


                                       40


Effective Time, to the extent that such  indemnification is provided pursuant to
the Certificate of Incorporation or Bylaws of the Company on the date hereof and
is permitted under the DGCL.

                                   SECTION 6
                 CONDITIONS PRECEDENT TO OBLIGATIONS OF ACQUIROR

         The  obligations  of  Acquiror  to  effect  the  Merger  and  otherwise
consummate the  transactions  contemplated  by this Agreement are subject to the
satisfaction, at or prior to the Closing, of each of the following conditions:

         6.1 ACCURACY OF REPRESENTATIONS.  Each of the material  representations
and warranties of the Company  contained in this Agreement and those  agreements
set forth in Section 6.5 shall be accurate  in all  material  respects as of the
Closing Date as if made on and as of the Closing Dates except for those material
representations and warranties as of a specific date, which shall be accurate in
all material respects as of such date.

         6.2  PERFORMANCE  OF COVENANTS.  Each  covenant or obligation  that the
Company is  required  to comply  with or to  perform at or prior to the  Closing
shall have been complied with and performed in all material respects.

         6.3 STOCKHOLDER APPROVAL. The Company shall have obtained in the manner
prescribed  by Section  5.10 above the  Requisite  Stockholder  Approval  and no
Person who is a holder of Company Common Stock or Company Preferred Stock, other
than Persons who in the  aggregate  hold not more than 10% of all the issued and
outstanding  shares of Company  Common Stock as of the Closing Date,  shall have
given  written  notice of their  intent to demand  payment  for their  shares of
Company Common Stock or Company Preferred Stock and shall not have voted for the
Merger, pursuant to Section 262 of the Delaware General Corporation Law, Section
2115 of the GCLC or other applicable state law.

         6.4  CONSENTS.  The  Consents  identified  in Part  6.4 of the  Company
Disclosure  Schedule  shall  have been  obtained  and shall be in full force and
effect.

         6.5  AGREEMENTS  AND  DOCUMENTS.  Acquiror  and the Company  shall have
received the following agreements and documents,  each of which shall be in full
force and effect:

         (a) Escrow Agreement in the form of Exhibit B, with such changes as may
be reasonably  requested by the Escrow Agent  thereunder,  executed on behalf of
the Stockholders;

         (b) such legal and tax opinion(s) as the Parties shall agree, including
a tax opinion of Ernst & Young,  LLP, dated as of the Closing Date and addressed
to  Acquiror,  to the effect that the Merger will  constitute  a  reorganization
within the meaning of Section 368(a) of the Code; provided,  however, if Ernst &
Young,  LLP does not render such opinion or withdraws or modifies  such opinion,
this  condition  shall  nonetheless  be deemed to be satisfied if Womble Carlyle
Sandridge & Rice,  PLLC renders  such  opinion to Acquiror (it being  understood
that in rendering such opinion,  Ernst & Young, LLP and Womble Carlyle Sandridge
& Rice, PLLC, as the case may be, may rely upon the tax  representation  letters
referred to in Section 5.7);

                                       41


         (c) a  certificate  executed  on  behalf  of the  Company  by its Chief
Executive Officer confirming that the conditions set forth in Sections 6.1, 6.2,
6.3, 6.4, 6.5(d), 6.6, 6.8, and 6.9 have been duly satisfied;

         (d) written  termination,  effective as of the Effective Time, of those
agreements referred to in Section 5.8(a) and (e); and

         (e) a stock power or other appropriate transfer documentation providing
for the  transfer of the  share(s)  of Belgium  Sub common  stock owned by David
Tahmassebi to Acquiror or its designee.

         6.6 NO MATERIAL ADVERSE EFFECT. Since the date of this Agreement, there
shall not have  occurred  any  Material  Adverse  Effect on the  Company  or its
business,  and no event shall have  occurred or  circumstance  shall exist that,
alone or in combination with any other events or circumstances, could reasonably
be expected to have a Material Adverse Effect on the Company or its business.

         6.7 HSR ACT. Any waiting period  applicable to the  consummation of the
Merger  under the HSR Act shall have  expired  or been  terminated  and,  on the
Closing  Date,  there  shall not be in effect any  voluntary  agreement  between
Acquiror and the Federal Trade  Commission or the Department of Justice pursuant
to which Acquiror has agreed not consummate the Merger for a period of time; any
similar waiting period under any applicable  foreign antitrust law or regulation
shall have  expired  or been  terminated;  and any  Consent  required  under any
applicable foreign antitrust law or regulation shall have been obtained.

         6.8 NO  RESTRAINTS.  No temporary  restraining  order,  preliminary  or
permanent  injunction or other order  preventing the  consummation of the Merger
shall  have been  issued by any court of  competent  jurisdiction  and remain in
effect,  and  there  shall  not be  any  Legal  Requirement  enacted  or  deemed
applicable to the Merger that makes consummation of the Merger illegal.

         6.9  NO  GOVERNMENTAL  LITIGATION.   There  shall  not  be  pending  or
threatened any Legal Proceeding in which a Governmental Body is or is threatened
to become a party or is  otherwise  involved:  (a)  challenging  or  seeking  to
restrain  or  prohibit  the  consummation  of the  Merger  or  any of the  other
transactions  contemplated  by this  Agreement;  (b)  relating to the Merger and
seeking to obtain from  Acquiror  or any of its  Subsidiaries  any damages  that
could reasonably be expected to be material to Acquiror; (c) seeking to prohibit
or limit in any material respect  Acquiror's  ability to vote, receive dividends
with respect to or otherwise exercise ownership rights with respect to the stock
of the Surviving  Corporation;  (d) which would  materially and adversely affect
the right of Acquiror,  the Surviving  Corporation or any Subsidiary of Acquiror
to own the assets or operate  the  business  of the  Company;  or (e) seeking to
compel Acquiror or the Company, or any Subsidiary of Acquiror or the Company, to
dispose of or hold  separate any material  assets,  as a result of the Merger or
any of the other transactions contemplated by this Agreement.

         6.10 CASH BALANCE.  As of the Closing  Date,  the Company shall have an
aggregate cash balance in its bank accounts of not less than  $35,000,000  minus
the sum of (A) and  (B),  where  (A) is  equal  to  $1,800,000  multiplied  by a
fraction the numerator of which is equal to the number of days between September
30, 2002 and the Closing Date and the  denominator  of which is equal to 30, and
(B) is equal to the  amount  set  forth on Part 6.10 of the  Company  Disclosure
Schedule.

                                       42


         6.11  PAYMENT OF EXPENSES.  Prior to the  Effective  Time,  the Company
shall have paid in full Credit  Suisse First Boston for any and all  obligations
for which the Company is liable.

                                   SECTION 7
                CONDITIONS PRECEDENT TO OBLIGATION OF THE COMPANY

         The  obligation  of the  Company to effect  the  Merger  and  otherwise
consummate the  transactions  contemplated  by this Agreement are subject to the
satisfaction, at or prior to the Closing, of the following conditions:

         7.1 ACCURACY OF REPRESENTATIONS.  Each of the material  representations
and warranties of Acquiror  contained in this Agreement shall be accurate in all
material  respects  as of the  Closing  Date as if made on and as of the Closing
Date except for those material  representations  and warranties as of a specific
date, which shall be accurate in all material respects as of such date.

         7.2 PERFORMANCE OF COVENANTS. All of the covenants and obligations that
Acquiror  is  required  to comply  with or to perform at or prior to the Closing
shall have been complied with and performed in all material respects.

         7.3 DOCUMENTS. The Company shall have received the following documents:

         (a) such  legal and tax  opinion(s)  as the  Parties  shall  agreement,
including a tax opinion of Ernst & Young,  LLP, dated as of the Closing Date, to
the effect that the Merger will constitute a  reorganization  within the meaning
of Section 368(a) of the Code; provided, however, if Ernst & Young, LLP does not
render such opinion or withdraws or modifies such opinion,  this condition shall
nonetheless  be deemed to be  satisfied  if Wilson,  Sonsini,  Goodrich & Rosati
renders such opinion to the Company (it being  understood that in rendering such
opinion,  Ernst & Young, LLP and Wilson Sonsini  Goodrich & Rosati,  as the case
may be,  may rely upon the tax  representation  letters  referred  to in Section
5.7); and

         (b) a  certificate  executed  on behalf  of  Acquiror  by an  executive
officer of Acquiror,  confirming  that the  conditions set forth in Sections 7.1
and 7.2 have been duly satisfied.

         7.4 HSR ACT. Any waiting period  applicable to the  consummation of the
Merger  under the HSR Act shall have  expired  or been  terminated  and,  on the
Closing  Date,  there  shall not be in effect any  voluntary  agreement  between
Acquiror and the Federal Trade  Commission or the Department of Justice pursuant
to which Acquiror has agreed not consummate the Merger for a period of time.

         7.5 NO  RESTRAINTS.  No temporary  restraining  order,  preliminary  or
permanent injunction or other order preventing the consummation of the Merger by
the Company  shall have been issued by any court of competent  jurisdiction  and
remain in effect, and there shall not be any Legal Requirement enacted or deemed
applicable  to the Merger that makes  consummation  of the Merger by the Company
illegal.

         7.6 NO MATERIAL ADVERSE EFFECT. Since the date of this Agreement, there
shall not have occurred any Material Adverse Effect on Acquiror or its business,
and no event shall have occurred or circumstance  shall exist that,  alone or in
combination with any other events or circumstances, could reasonably be expected
to have a Material Adverse Effect on Acquiror or its business.

                                       43


         7.7 PERMIT  APPLICATION  APPROVED;  REGISTRATION  STATEMENT  EFFECTIVE;
PROXY  STATEMENT.  Prior to the issuance of Acquiror  Common Stock in accordance
with  Section 1.5 above,  either (i)  Acquiror  shall have  received a favorable
determination  in the  Fairness  Hearing and have been issued a Permit  covering
such shares of Acquiror  Common Stock to the effect that the issuance  qualifies
for exemption  under the 3(a)(10)  exemption or (ii) the SEC shall have declared
the S-4 effective and no stop order  suspending the  effectiveness of the S-4 or
any part thereof shall have been issued and no proceeding for that purpose,  and
no similar proceeding in respect of the Proxy  Statement/Prospectus,  shall have
been initiated or threatened in writing by the SEC.

         7.8 EXCHANGE LISTING.  Prior to the Effective Time, Acquiror shall have
filed  with the  Nasdaq  National  Market a  Notification  Form for  Listing  of
Additional  Shares  with  respect  to the  Acquiror  Common  Stock to be  issued
pursuant to the Merger.

                                   SECTION 8
                                 INDEMNIFICATION

         8.1  INDEMNIFICATION BY STOCKHOLDERS.  Subject to Sections 8.7 and 8.8,
prior to the Effective  Time,  the Company,  and after the Effective  Time,  the
Company  Stockholders jointly and severally but only to the extent of the Escrow
Fund,  shall  indemnify,  defend  and hold  harmless  Acquiror  (and,  after the
Closing,  the Surviving  Corporation) from, against, and with respect to any and
all actions or causes of action,  losses,  damages (including without limitation
all foreseeable and unforeseeable  consequential damages), claims,  obligations,
liabilities,  penalties, fines, costs and expenses (including without limitation
reasonable  attorneys' and consultants'  fees and costs and expenses incurred in
investigating,  preparing,  defending  against or  prosecuting  any  litigation,
claim,  proceeding,  demand  or  request  for  action  by  any  governmental  or
administrative entity), of any kind or character (a "Loss") arising out of or in
connection   with  any  of  the  following:   (a)  any  breach  of  any  of  the
representations  or warranties  of the Company  contained in or made pursuant to
this Agreement;  or (b) any failure by the Company to perform or observe,  or to
have  performed or observed,  in full, any covenant or agreement to be performed
or observed by the Company  pursuant to this  Agreement;  (c) an amount equal to
the excess of (i) the aggregate  appraised  value of any  Dissenting  Stock over
(ii)(A) the  Average  Price  multiplied  by (B) the number of shares of Acquiror
Common  Stock that would have been  issuable to the  holders of such  Dissenting
Stock  pursuant to Section  1.5(a);  or (d) any other  matter  contained  in the
Escrow Agreement with respect to which the Company  Stockholders  have agreed to
indemnify Acquiror.

         8.2 INDEMNIFICATION BY THE COMPANY. The Company shall indemnify, defend
and hold harmless  Acquiror  from,  against and with respect to any and all Loss
arising  out of or in  connection  with any act or  omission by the Company or a
Stockholder  resulting in termination of this Agreement by Acquiror  pursuant to
Section 9.1(e) if such breach described therein was willful.

         8.3  INDEMNIFICATION  BY  ACQUIROR.  Subject to  Sections  8.7 and 8.8,
Acquiror shall indemnify, defend and hold harmless the Company from, against and
with  respect  to any  Loss  arising  out of or in  connection  with  any of the
following:  (a) any  breach  of any of the  representations  and  warranties  of
Acquiror  contained in or made  pursuant to this  Agreement;  (b) any failure by
Acquiror to perform or observe,  or to have performed or observed,  in full, any
covenant,  agreement  or condition to be performed or observed by it pursuant to
this Agreement; or (c) any and all Loss arising out of or in connection with any


                                       44


act or omission by the Acquiror  resulting in  termination  of this Agreement by
Company pursuant to Section 9.1(f) if such breach described therein was willful.

         8.4 NOTICE OF CLAIM. Any party seeking to be indemnified hereunder (the
"Indemnified Party") shall notify as promptly as practicable the party from whom
indemnity is sought (the "Indemnity Obligor"),  and, if the Company Stockholders
are the Indemnity  Obligor,  the Escrow Agent named in the Escrow Agreement,  of
any claim for recovery,  specifying in reasonable  detail the nature of the Loss
and the amount of the liability  estimated to arise  therefrom.  The Indemnified
Party shall  provide to the  Indemnity  Obligor and, if  applicable,  the Escrow
Agent, as promptly as practicable  thereafter all information and  documentation
reasonably  requested  by the  Indemnity  Obligor to verify the claim  asserted.
Notice to the  Company  Stockholders  shall be  delivered  to the  Stockholders'
Representatives.

         8.5 DEFENSE.  If the facts  pertaining to a Loss arise out of the claim
of any third party (including,  without limitation, any dissenting stockholder),
or if there is any  claim  against  a third  party  available  by  virtue of the
circumstances  of the Loss, the Indemnity  Obligor may, by giving written notice
to the  Indemnified  Party within 30 days following its receipt of the notice of
such claim,  elect to assume the defense or the prosecution  thereof,  including
the  employment  of counsel or  accountants  at its cost and expense;  provided,
however,  that  during the  interim  the  Indemnified  Party  shall use its best
efforts to take all action (not including  settlement)  reasonably  necessary to
protect against further damage or loss with respect to the Loss. The Indemnified
Party shall have the right to employ counsel  separate from counsel  employed by
the Indemnity  Obligor in any such action and to  participate  therein,  but the
fees and  expenses  of such  counsel  shall be at the  Indemnified  Party's  own
expense unless counsel to the Indemnified Party reasonably  concludes that there
would be a conflict  of interest if counsel  selected by the  Indemnity  Obligor
represented the Indemnified Party in the matter. In such event, the fees of such
separate counsel shall constitute a Loss.  Whether or not the Indemnity  Obligor
chooses so to defend or  prosecute  such  claim,  all the parties  hereto  shall
cooperate in the defense or prosecution  thereof and shall furnish such records,
information  and  testimony  and  shall  attend  such   conferences,   discovery
proceedings and trials as may be reasonably  requested in connection  therewith.
The Indemnity  Obligor shall not be liable for any  settlement of any such claim
effected  without its prior  written  consent,  which shall not be  unreasonably
withheld.

         8.6 OTHER  REMEDIES.  The foregoing  indemnification  provisions are in
addition  to, and not in  derogation  or  limitation  of,  any other  rights and
remedies  of  the  parties  at law  (other  than  money  damages)  or in  equity
(including specific performance).

         8.7  MAXIMUM  INDEMNITY  AMOUNT.  Notwithstanding  any other  provision
hereof,  an  Indemnified  Party  may  recover  the  amount  of any Loss from the
Indemnity  Obligator only if (but not only to the extent that) the amount of the
Loss, when added to all other Losses incurred by the  Indemnified  Party,  shall
exceed  $100,000.  The liabilities of each Company  Stockholder  hereunder as an
Indemnity  Obligor  shall  further  be  limited  to that  portion  of the Merger
Consideration  attributable to such Company  Stockholder by virtue of the shares
of  Company  Common  Stock and  Company  Preferred  Stock  held by such  Company
Stockholder  that  is  held  in  escrow  pursuant  to the  terms  of the  Escrow
Agreement.  In the event that Acquiror or the Surviving Corporation shall suffer
a Loss subject to indemnity hereunder by the Company Stockholders,  and Acquiror
or the  Surviving  Corporation  shall  deliver a notice  thereof as  provided in
Section  8.4 to the  Stockholders'  Representative  and the Escrow  Agent,  such
Indemnified  Party  shall be  entitled  to recover up to the full amount of such
Loss from the portion of the Merger  Consideration  held  pursuant to the Escrow


                                       45


Agreement, subject to the terms thereof.

         8.8 TIME  LIMITATIONS.  Any claim asserted pursuant to Section 8.1, 8.2
or 8.3 must be submitted to the Indemnity Obligor pursuant to Section 8.4 within
one year after the Closing Date in order for there to be any  obligation  of the
Indemnity Obligor to indemnify with respect to any such claim.

         8.9  WAIVER OF  CONDITIONS.  The waiver of any  condition  set forth in
either  Section 6 or Section 7 shall not prevent,  bar or negatively  impact the
assertion of a Loss for which indemnification is sought pursuant to this Section
8.

                                   SECTION 9
                                   TERMINATION

         9.1  TERMINATION.  This  Agreement  may  be  terminated  prior  to  the
Effective Time (whether  before or after approval of the principal  terms of the
Merger by the Company's stockholders):

         (a) by mutual written consent of Acquiror and the Company;

         (b) by either Acquiror or the Company if the Merger shall not have been
consummated  by the End Date (as defined  below in this Section 9.1) (unless the
failure to consummate the Merger is attributable to a failure on the part of the
party  seeking to terminate  this  Agreement to perform any material  obligation
required to be performed by such party at or prior to the Effective Time);

         (c)  by  either  Acquiror  or  the  Company  if a  court  of  competent
jurisdiction  or  other   Governmental  Body  shall  have  issued  a  final  and
nonappealable  order,  decree or ruling,  or shall have taken any other  action,
having the effect of permanently restraining, enjoining or otherwise prohibiting
the Merger;

         (d) by either Acquiror or the Company if the Company Stockholders shall
have  taken a final  vote on,  and  shall  not have  approved  by the  Requisite
Stockholder  Approval,  a proposal to approve the  Agreement  and the  principal
terms of the Merger;  provided,  however, that a party shall not be permitted to
terminate  this  Agreement  pursuant  to this  Section  9.1(d) if the failure to
obtain such Requisite  Stockholder  Approval is attributable to a failure on the
part of such party to perform any material  obligation  required to be performed
by such party at or prior to the Effective Time;

         (e) by Acquiror if (i) the  Company's  representations  and  warranties
contained  in  this  Agreement  shall  be  inaccurate  as of the  date  of  this
Agreement,  or shall have become  inaccurate as of a date subsequent to the date
of this Agreement (as if made on such subsequent  date), such that the condition
set forth in Section 6.1 would not be satisfied (it being  understood  that, for
purposes of determining the accuracy of such  representations  and warranties as
of the date of this  Agreement  or at any  subsequent  date,  any  update  of or
modification to the Company  Disclosure  Schedule made or purported to have been
made  after  the  date of this  Agreement  shall  be  disregarded),  or (ii) the
Company's  covenants  contained in this Agreement  shall have been breached such
that the condition  set forth in Section 6.2 would not be  satisfied;  provided,
however,  that if an inaccuracy in the Company's  representations and warranties
or a breach of a covenant  by the  Company is  curable  by the  Company  and the
Company is continuing to exercise all  commercially  reasonable  efforts to cure
such inaccuracy or breach,  then Acquiror may not terminate this Agreement under


                                       46


this  Section  9.1(e) on account of such  inaccuracy  or breach prior to the End
Date; or

         (f) by  the  Company  if (i)  any  of  Acquiror's  representations  and
warranties  contained in this  Agreement  shall be  inaccurate as of the date of
this Agreement,  or shall have become  inaccurate as of a date subsequent to the
date of this  Agreement  (as if made on such  subsequent  date),  such  that the
condition set forth in Section 7.1 would not be satisfied  (it being  understood
that,  for  purposes of  determining  the accuracy of such  representations  and
warranties  as of the date of this  Agreement  or at any  subsequent  date,  any
update of or modification to the Acquiror  Disclosure Schedule made or purported
to have been made after the date of this  Agreement  shall be  disregarded),  or
(ii) if any of Acquiror's  covenants contained in this Agreement shall have been
breached  such  that  the  condition  set  forth in  Section  7.2  would  not be
satisfied;   provided,   however,   that   if  an   inaccuracy   in   Acquiror's
representations  and warranties or a breach of a covenant by Acquiror is curable
by Acquiror and Acquiror is continuing to exercise all  commercially  reasonable
efforts to cure such  inaccuracy  or breach,  then the Company may not terminate
this Agreement under this Section 9.1(f) on account of such inaccuracy or breach
prior to the End Date.

For purposes of Section 9.1(b), the term "End Date" shall mean January 31, 2003;
provided,  however,  that if on  January  31,  2003 (i) (A) any  waiting  period
applicable  to the  consummation  of the Merger under the HSR Act shall not have
expired or been  terminated  or there shall be in effect a  voluntary  agreement
between  Acquiror and the Federal Trade  Commission or the Department of Justice
pursuant to which  Acquiror has agreed not to consummate the Merger for a period
of time or a temporary  restraining  order issued upon the motion of the Federal
Trade  Commission  or the  Department  of  Justice is in effect  precluding  the
consummation of the Merger,  (B) any similar waiting period under any applicable
foreign  antitrust law or regulation  shall not have expired or been terminated,
(C)  any  Consent  required  under  any  applicable  foreign  antitrust  law  or
regulation  shall not have been  obtained,  or (D) a final  decision has not yet
been  rendered by the hearing  examiner in the  Fairness  Hearing,  and (ii) all
other  conditions  contained  in Section 6 and Section 7 that are not related to
any of the matters  referred to in clause "(A)",  "(B)",  "(C)" or "(D)" of this
sentence shall have been  satisfied or waived,  then the End Date shall be March
31, 2003.

         9.2  EFFECT OF  TERMINATION.  In the event of the  termination  of this
Agreement  as provided in Section  9.1,  this  Agreement  shall be of no further
force or effect;  provided,  however,  that (i) Section  8.2,  this Section 9.2,
Section 9.3 and Section 10 shall survive the  termination  of this Agreement and
shall  remain  in full  force  and  effect,  and  (ii) the  termination  of this
Agreement  shall not relieve any party from any liability for any willful breach
of any representation, warranty or covenant contained in this Agreement.

         9.3 EXPENSES.  Except as otherwise  expressly provided herein, all fees
and expenses  incurred in connection  with this  Agreement and the  transactions
contemplated  by  this  Agreement  shall  be paid by the  party  incurring  such
expenses, whether or not the Merger is consummated.

                                   SECTION 10
                            MISCELLANEOUS PROVISIONS

         10.1 AMENDMENT.  This Agreement may be amended with the approval of the
respective  boards of directors of the Company and Acquiror at any time prior to
the Effective Time; provided,  however, that after approval of the Merger by the


                                       47


Company  Stockholders  no amendment  may be made which by law  requires  further
approval  by the  Company  Stockholders  without  such  further  approval.  This
Agreement may not be amended except by an instrument in writing signed on behalf
of each of the parties hereto.

         10.2 WAIVER.

         (a) No failure on the part of any party to exercise  any power,  right,
privilege or remedy under this Agreement,  and no delay on the part of any party
in exercising any power, right, privilege or remedy under this Agreement,  shall
operate as a waiver of such power, right,  privilege or remedy; and no single or
partial  exercise of any such power,  right,  privilege or remedy shall preclude
any other or further exercise thereof or of any other power, right, privilege or
remedy.

         (b) No party  shall be deemed to have  waived any claim  arising out of
this Agreement,  or any power, right,  privilege or remedy under this Agreement,
unless the waiver of such claim, power, right,  privilege or remedy is expressly
set forth in a written  instrument duly executed and delivered on behalf of such
party;  and any such waiver shall not be applicable or have any effect except in
the specific instance in which it is given.

         10.3 SURVIVAL OF  REPRESENTATIONS  AND  WARRANTIES.  Subject to Section
8.8, all  representations and warranties made by the Company or Acquiror in this
Agreement  or in  any  document,  exhibit,  schedule  or  certificate  furnished
pursuant hereto or in connection  herewith,  shall survive the Closing until the
first anniversary of the Closing, at which time they shall expire. All covenants
and agreements  shall survive the Closing for the time periods set forth herein.
The right to  indemnification,  payment of damages or other  remedy based on the
representations and warranties contained herein and on covenants, agreements and
obligations  herein of Acquiror,  the Company or of any of the Stockholders will
not be affected by any investigation  conducted by such other party with respect
to, or any knowledge acquired (or capable of being acquired) at any time by such
other  party,  whether  before  or after  the  execution  and  delivery  of this
Agreement or the Closing Date,  with respect to the accuracy or inaccuracy of or
compliance  with,  any such  representation,  warranty,  covenant,  agreement or
obligation.   The  waiver  of  any  condition  based  on  the  accuracy  of  any
representation  or warranty,  or on the  performance  of or compliance  with any
covenant,  agreement  or  obligation,  or any  extension  granted  with  respect
thereto,  will not  affect the right to  indemnification,  payment of damages or
other  remedy based on such  representation,  warranty,  covenant,  agreement or
obligation.

         10.4 ENTIRE  AGREEMENT;  COUNTERPARTS.  This Agreement  constitutes the
entire agreement and supersedes all other prior  agreements and  understandings,
both  written and oral,  among or between any of the parties with respect to the
subject  matter  hereof and thereof.  This  Agreement may be executed in several
counterparts,  each of which shall be deemed an original  and all of which shall
constitute one and the same instrument.

         10.5 APPLICABLE LAW; JURISDICTION. This Agreement shall be governed by,
and  construed  in  accordance  with,  the laws of the State of North  Carolina,
regardless of the laws that might otherwise govern under  applicable  principles
of conflicts of laws thereof.  In any action between any of the parties  arising
out of or relating to this Agreement or any of the transactions  contemplated by
this Agreement: (a) each of the parties irrevocably and unconditionally consents
and  submits to the  exclusive  jurisdiction  and venue of the state and federal
courts  located  in the  State of North  Carolina;  (b) if any  such  action  is


                                       48


commenced  in a state court,  then,  subject to  applicable  law, no party shall
object to the removal of such action to any federal  court located in the Middle
District of North Carolina;  (c) each of the parties,  to the extent such waiver
is enforceable  under applicable law,  irrevocably  waives the right to trial by
jury; and (d) each of the parties irrevocably  consents to service of process by
first class certified mail, return receipt  requested,  postage prepaid,  to the
address  at which such party is to receive  notice in  accordance  with  Section
10.8.

         10.6 ATTORNEYS' FEES. In any action at law or suit in equity to enforce
this  Agreement or the rights of any of the parties  hereunder,  the  prevailing
party in such action or suit shall be entitled to receive a  reasonable  sum for
its attorneys' fees and all other reasonable costs and expenses incurred in such
action or suit.

         10.7 ASSIGNABILITY.  This Agreement shall be binding upon, and shall be
enforceable  by and inure solely to the benefit of, the parties hereto and their
respective successors and assigns;  provided,  however, that, except as provided
in Section 1.11 above,  neither this  Agreement nor any of the rights  hereunder
may be assigned  by any party  without  the prior  written  consent of the other
parties,  and any attempted  assignment of this  Agreement or any of such rights
hereunder  without such consent shall be void and of no effect.  Nothing in this
Agreement,  express or implied,  is intended to or shall  confer upon any Person
(other  than the  parties  hereto)  any  right,  benefit or remedy of any nature
whatsoever under or by reason of this Agreement.

         10.8 NOTICES.  Any notice or other communication  required or permitted
to be delivered to any party under this Agreement  shall be in writing and shall
be deemed  properly  delivered,  given and received when  delivered (by hand, by
registered  mail, by courier or express delivery service or by facsimile) to the
address or facsimile  telephone  number  (confirmed  received by recipient)  set
forth  beneath  the  name of such  party  below  (or to such  other  address  or
facsimile  telephone  number as such  party  shall have  specified  in a written
notice given to the other parties hereto):

         If to Acquiror:

         Mr. David Norbury
         Chief Executive Officer
         7628 Thorndike Road
         Greensboro, North Carolina 27409

         Fax:  336-664-0484

         With a copy to:

         Jeffrey C. Howland, Esq.
         Womble Carlyle Sandridge & Rice, PLLC
         One West Fourth Street
         Post Office Drawer 84
         Winston-Salem, North Carolina 27102
         Fax: (336) 733-8371

                                       49


         If to the Company:

         Mr. David Tahmassebi
         1754 Technology Drive, Suite 200
         San Jose, California 95110

         Fax:  408-436-3943

         With a copy to:

         Michael J. Kennedy, Esq.
         Wilson Sonsini Goodrich & Rosati
         One Market, Spear Street Tower
         San Francisco, California   94105
         Fax:  (415) 947-2099

         10.9  COOPERATION.  The Company agrees to cooperate fully with Acquiror
and to execute and deliver such further documents, certificates,  agreements and
instruments  and to take such other  actions as may be  reasonably  requested by
Acquiror to evidence or reflect the transactions  contemplated by this Agreement
and to carry out the intent and purposes of this Agreement.

         10.10 CONSTRUCTION.

         (a) For purposes of this Agreement,  whenever the context requires: the
singular number shall include the plural,  and vice versa;  the masculine gender
shall include the feminine and neuter genders; the feminine gender shall include
the masculine and neuter genders;  and the neuter gender shall include masculine
and feminine genders.

         (b) The  parties  hereto  agree  that any rule of  construction  to the
effect that  ambiguities are to be resolved against the drafting party shall not
be applied in the construction or interpretation of this Agreement.

         (c) As used in this Agreement, the words "include" and "including," and
variations  thereof,  shall not be deemed to be terms of limitation,  but rather
shall be deemed to be followed by the words "without limitation."

         (d) Except as otherwise indicated,  all references in this Agreement to
"Sections"  and  "Exhibits"  are intended to refer to Sections of this Agreement
and Exhibits to this Agreement.

         (e) Each of the  statements set forth in the Recitals to this Agreement
are incorporated herein as the valid and binding representations of the party or
parties to which they refer.

                  [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]



                                       50




         IN WITNESS  WHEREOF,  the  parties  have caused  this  Agreement  to be
executed as of the date first above written.

                          RF MICRO DEVICES, INC.

                          By: /s/ Jerry D. Neal
                              -------------------------------------------------
                                 Name: Jerry D. Neal
                                      -----------------------------------------
                                 Title: Executive Vice President of Marketing
                                        and Strategic Development
                                       ----------------------------------------



                          RESONEXT COMMUNICATIONS, INC.

                          By: /s/ David Tahmassebi
                              -------------------------------------------------
                                 Name:  David Tahmassebi
                                       ----------------------------------------
                                 Title: President and CEO
                                       ----------------------------------------


THE UNDERSIGNED  STOCKHOLDER IS EXECUTING THIS AGREEMENT  SOLELY FOR THE PURPOSE
OF  CONSENTING TO ACT AS THE  STOCKHOLDERS'  REPRESENTATIVE  IN ACCORDANCE  WITH
SECTION 1.8 ABOVE.
                          /s/ Robert B. Abbott
                          -------------------------------------------------
                          Name:  Robert B. Abbott





                                    EXHIBIT A
                               CERTAIN DEFINITIONS

         For purposes of the Agreement (including this Exhibit A):

         ACQUIROR  COMMON STOCK.  "Acquiror  Common Stock" shall mean the Common
Stock, no par value, of Acquiror,  with Acquiror Preferred Stock purchase rights
attached  and issued  pursuant to the Rights  Agreement,  dated August 10, 2001,
between Acquiror and First Union National Bank, as Rights Agent.

         ACQUIROR DISCLOSURE SCHEDULE. "Acquiror Disclosure Schedule" shall mean
the  disclosure  schedule  that has been  prepared by Acquiror and that has been
delivered by Acquiror to the Company on the date of this Agreement and signed by
the President of the Acquiror.

         ACQUIROR  PREFERRED  STOCK.  "Acquiror  Preferred Stock" shall mean the
Preferred Stock, no par value, of Acquiror.

         ACQUIROR  UNAUDITED BALANCE SHEET.  "Acquiror  Unaudited Balance Sheet"
shall  mean  the  unaudited  consolidated  balance  sheet  of  Acquiror  and its
consolidated  Subsidiaries  as of June 30,  2002  included in the  Acquiror  SEC
Documents.

         ACQUISITION  PROPOSAL.  "Acquisition  Proposal"  shall  mean any offer,
proposal,  inquiry or  indication  of interest  (other than an offer,  proposal,
inquiry or  indication  of  interest by  Acquiror)  contemplating  or  otherwise
relating to any Acquisition Transaction.

         ACQUISITION  TRANSACTION.  "Acquisition  Transaction"  shall  mean  any
transaction or series of transactions involving:

         (a) any merger,  consolidation,  share exchange,  business combination,
issuance of securities,  acquisition of securities, tender offer, exchange offer
or  other  similar  transaction  (i)  in  which  the  Company  is a  constituent
corporation,  (ii) in which a Person or "group" (as defined in the  Exchange Act
and the rules promulgated thereunder) of Persons directly or indirectly acquires
beneficial or record ownership of securities  representing  more than 20% of the
outstanding  securities  of any class of voting  securities  of the Company,  or
(iii) in which the Company issues  securities  representing more than 20% of the
outstanding securities of any class of voting securities of the Company;

         (b) any  sale,  lease,  exchange,  transfer,  license,  acquisition  or
disposition of (i) any Company  Subsidiary or (ii) any business or businesses or
assets  that  constitute  or account  for 20% or more of the net  revenues,  net
income or assets of the Company; or

         (c) any  liquidation  or  dissolution  of the  Company  or any  Company
Subsidiary.

         AFFILIATE.  "Affiliate" of a specified Person shall mean (i) any Person
directly or indirectly  controlling,  controlled by or under common control with
the specified Person;  (ii) any Person owning or controlling ten percent or more
of the outstanding voting securities of the specified Person; (iii) any officer,





director or partner of the specified  Person; or (iv) if the specified Person is
an officer,  director or partner, any entity for which the specified Person acts
in such capacity.

         AGREEMENT.  "Agreement" shall mean the Agreement and Plan of Merger and
Reorganization  to which this Exhibit A is  attached,  as it may be amended from
time to time.

         COMPANY  COMMON  STOCK.  "Company  Common  Stock" shall mean the Common
Stock, $0.001 par value per share, of the Company.

         COMPANY CONTRACT.  "Company  Contract" shall mean any Contract:  (a) to
which  the  Company  is a party;  (b) by which the  Company  or any asset of the
Company is or may become  bound or under  which the  Company  has, or may become
subject  to, any  obligation;  or (c) under which the Company has or may acquire
any right or interest.

         COMPANY DISCLOSURE  SCHEDULE.  "Company Disclosure Schedule" shall mean
the disclosure  schedule that has been prepared by the Company and that has been
delivered by the Company to Acquiror on the date of this Agreement and signed by
the President of the Company.

         COMPANY  PREFERRED  STOCK.  "Company  Preferred  Stock"  shall mean the
Preferred Stock, $0.001 par value per share, of the Company consisting of Series
A Preferred  Stock,  Series B Preferred  Stock and Series C Preferred  Stock, as
more  fully  described  in  the  Sixth  Amended  and  Restated   Certificate  of
Incorporation of Resonext Communications,  Inc.. Each of such series is referred
to in the Agreement with the preface "Company" and the name of such series.

         COMPANY PROPRIETARY ASSET.  "Company  Proprietary Asset" shall mean any
Proprietary  Asset owned by or licensed to the Company or otherwise  used by the
Company.

         COMPANY  STOCKHOLDERS.  "Company  Stockholders"  shall have the meaning
provided in Section 1.5(d) of the Agreement.

         CONSENT.  "Consent"  shall mean any  approval,  consent,  ratification,
permission, waiver or authorization (including any Governmental Authorization).

         CONTRACT.  "Contract" shall mean any written,  oral or other agreement,
contract, subcontract, lease, understanding, instrument, note, option, warranty,
purchase order, license,  sublicense,  insurance policy, benefit plan or legally
binding commitment or undertaking of any nature.

         ENCUMBRANCE.  "Encumbrance" shall mean any lien, pledge, hypothecation,
charge,  mortgage,   security  interest,   encumbrance,   claim,   infringement,
interference,  option,  right  of first  refusal,  preemptive  right,  community
property interest or restriction of any nature (including any restriction on the
voting of any security, any restriction on the transfer of any security or other
asset,  any restriction on the receipt of any income derived from any asset, any
restriction  on the use of any  asset  and any  restriction  on the  possession,
exercise or transfer of any other attribute of ownership of any asset).

         ENTITY.  "Entity" shall mean any corporation  (including any non-profit
corporation),   general  partnership,  limited  partnership,  limited  liability
partnership,  joint  venture,  estate,  trust,  company  (including  any limited


                                       2


liability   company  or  joint  stock  company),   firm  or  other   enterprise,
association, organization or entity.

         ERISA.  "ERISA" means the Employee  Retirement  Income  Security Act of
1974, as amended, and the regulations issued thereunder.

         EXCHANGE ACT. "Exchange Act" shall mean the Securities  Exchange Act of
1934, as amended.

         GOVERNMENTAL  AUTHORIZATION.  "Governmental  Authorization"  shall mean
any:  (a)  permit,  license,  certificate,   franchise,   permission,  variance,
clearance,  registration,  qualification or authorization issued, granted, given
or otherwise made available by or under the authority of any  Governmental  Body
or pursuant to any Legal  Requirement;  or (b) right under any Contract with any
Governmental Body.

         GOVERNMENTAL  BODY.  "Governmental  Body"  shall mean any:  (a) nation,
state, commonwealth,  province,  territory,  county,  municipality,  district or
other jurisdiction of any nature; (b) federal, state, local, municipal,  foreign
or other government; or (c) governmental or quasi-governmental  authority of any
nature (including any governmental  division,  department,  agency,  commission,
instrumentality,  official,  organization, unit, body or Entity and any court or
other tribunal).

         HSR  ACT.  "HSR  Act"  shall  mean  the   Hart-Scott-Rodino   Antitrust
Improvements Act of 1976, as amended.

         KNOWLEDGE.  "Knowledge"  shall mean,  as used with respect to a Person,
the personal knowledge,  after due inquiry, of any executive officer,  member of
the  board  of  directors,   executive,  manager,  or  other  individual  having
responsibility  for the operations of any significant  business unit or internal
function of such Person.

         LEGAL  PROCEEDING.  "Legal  Proceeding"  shall mean any  action,  suit,
litigation,    arbitration,   proceeding   (including   any   civil,   criminal,
administrative, investigative or appellate proceeding), hearing, inquiry, audit,
examination  or  investigation  commenced,  brought,  conducted  or  heard by or
before,  or otherwise  involving,  any court or other  Governmental  Body or any
arbitrator or arbitration panel.

         LEGAL REQUIREMENT.  "Legal Requirement" shall mean any federal,  state,
local,  municipal,  foreign or other law,  statute,  constitution,  principle of
common law, resolution, ordinance, code, edict, decree, rule, regulation, ruling
or requirement issued, enacted, adopted,  promulgated,  implemented or otherwise
put into effect by or under the authority of any Governmental Body (or under the
authority of the NASD).

         MATERIAL ADVERSE EFFECT. An event, violation, inaccuracy,  circumstance
or other  matter  will be  deemed to have a  "Material  Adverse  Effect"  on the
Company or on Acquiror if such event,  violation,  inaccuracy,  circumstance  or
other matter  (considered  together with all other matters that would constitute
exceptions to the  representations and warranties set forth in the Agreement but
for  the   presence  of   "Material   Adverse   Effect"  or  other   materiality
qualifications,  or any  similar  qualifications,  in such  representations  and
warranties)  had or could  reasonably  be  expected  to have a material  adverse


                                       3


effect on (i) the  business,  condition,  capitalization,  assets,  liabilities,
operations,  or financial  performance of the Company or any Company Subsidiary,
or Acquiror or any  Subsidiary  of Acquiror,  as  applicable  (in any case,  the
"Affected  Party") or (ii) the ability of the Affected  Party to consummate  the
Merger or any of the other  transactions  contemplated  by the  Agreement  or to
perform any of its obligations under the Agreement;  PROVIDED,  HOWEVER,  that a
"Material  Adverse  Effect"  shall not be deemed to include any  change,  event,
violation, inaccuracy,  circumstance or effect (i) relating to the United States
economy or United  States  financial  markets in general;  (ii)  relating to the
industry or industries in which such entity operates or conducts business; (iii)
relating to compliance by the Affected Party or its Subsidiaries  with the terms
of this  Agreement;  or (iv) resulting from the  announcement or pendency of the
Merger.

         PERSON.  "Person"  shall mean any  individual,  Entity or  Governmental
Body.

         PROPRIETARY  ASSET.  "Proprietary  Asset"  shall mean any:  (a) patent,
patent application,  trademark (whether  registered or unregistered),  trademark
application,  trade  name,  fictitious  business  name,  service  mark  (whether
registered  or  unregistered),  service  mark  application,  copyright  (whether
registered  or  unregistered),   copyright   application,   maskwork,   maskwork
application,  trade secret, know-how, customer list, franchise, system, computer
software,   computer  program,  source  code,  algorithm,   invention,   design,
blueprint,  engineering drawing,  proprietary product,  technology,  proprietary
right or other intellectual  property right or intangible asset; or (b) right to
use or exploit any of the foregoing.

         REPRESENTATIVES.  "Representatives"  shall  mean  officers,  directors,
employees, agents, attorneys, accountants, advisors and representatives.

         REQUISITE STOCKHOLDER APPROVAL.  "Requisite Stockholder Approval" shall
have the meaning provided in Section 2.4 of this Agreement.

         SEC.  "SEC"  shall  mean the  United  States  Securities  and  Exchange
Commission.

         SECURITIES ACT. "Securities Act" shall mean the Securities Act of 1933,
as amended.

         SUBSIDIARY.  An entity shall be deemed to be a "Subsidiary"  of another
Person if such Person  directly or indirectly  owns,  beneficially or of record,
(a) an amount of voting  securities  of other  interests  in such Entity that is
sufficient to enable such Person to elect at leased a majority of the members of
such Entity's board of directors or other governing body, or (b) at least 50% of
the outstanding equity or financial interests of such Entity.

         TAX. "Tax" shall mean any tax (including any income tax, franchise tax,
capital gains tax, gross receipts tax,  value-added tax, surtax,  excise tax, ad
valorem tax, transfer tax, stamp tax, sales tax, use tax, property tax, business
tax, withholding tax or payroll tax), levy, assessment,  tariff, duty (including
any  customs  duty),  deficiency  or  fee,  and any  related  charge  or  amount
(including any fine, penalty or interest),  imposed, assessed or collected by or
under the authority of any Governmental Body.

         TAX  RETURN.   "Tax  Return"  shall  mean  any  return  (including  any
information return), report, statement, declaration, estimate, schedule, notice,
notification, form, election, certificate or other document or information filed


                                       4


with or  submitted  to,  or  required  to be filed  with or  submitted  to,  any
Governmental Body in connection with the determination,  assessment,  collection
or payment of any Tax or in connection with the  administration,  implementation
or enforcement of or compliance with any Legal Requirement relating to any Tax.

                                       5





                               AMENDMENT NO. 1 TO
                 AGREEMENT AND PLAN OF MERGER AND REORGANIZATION

         THIS AMENDMENT NO. 1 TO AGREEMENT AND PLAN OF MERGER AND REORGANIZATION
(this  "Amendment")  is made and entered into as of November  21,  2002,  by and
between RF MICRO DEVICES, INC., a North Carolina corporation  ("Acquiror"),  and
RESONEXT   COMMUNICATIONS,   INC.,  a  Delaware   corporation  (the  "Company").
Capitalized  terms that are not otherwise  defined shall have the meanings given
to them in the Agreement and Plan of Merger and Reorganization  between Acquiror
and the Company dated as of October 15, 2002 (the "Original Agreement").

                                    RECITALS

         A.  Acquiror and the Company have entered into the Original  Agreement,
which provides for a Merger of the Company into and with Acquiror.

         B. Acquiror has filed an Application  for  Qualification  of Securities
with  the  Department  of   Corporations   of  the  State  of  California   (the
"Department"),  pursuant to Section 25121 of the  California  Securities  Law of
1968; and in connection with its review of such Application,  the Department has
required  that Section  1.13 of the Original  Agreement be amended to reduce the
Restricted Period applicable to certain Company  Stockholders in connection with
their sales of Merger Stock after the Effective Time.

         C. The respective  boards of directors of Acquiror and the Company have
approved this Amendment.

                                    AGREEMENT

         In  consideration  of the  foregoing  and of other  good  and  valuable
consideration the receipt and sufficiency of which are hereby acknowledged,  the
parties to this Amendment, intending to be legally bound, agree as follows:

         1. Section 1.13 of the Original Agreement is hereby amended as follows:

                  (a) Clause  (B)(y) of the proviso  that  follows  subparagraph
(a)(ii)  of Section  1.13 is hereby  amended  to change  "twelve  months" to "90
days".

                  (b) Clause (ii) of the  definition of  "Restricted  Period" in
the  penultimate  sentence  of Section  1.13(a) is hereby  amended to change "24
months" to "180 days".

         2. Except as amended as provided  for in this  Amendment,  the Original
Agreement  shall  remain in full  force and  effect.  All of the  provisions  of
Section 10 of the  Original  Agreement  shall  apply to this  Amendment  just as
though  Section  10 were  set  forth  in full in this  Amendment.  The  Original
Agreement is hereby  deemed to be further  amended as necessary to conform it to
the terms of this Amendment.




         IN WITNESS  WHEREOF,  the  parties  have caused  this  Amendment  to be
executed as of the date first above written.

                          RF MICRO DEVICES, INC.

                          By: /s/ William J. Pratt
                          ----------------------------------------------
                          Name: William J. Pratt
                          ----------------------------------------------
                          Title: Chief Technical Officer
                          ----------------------------------------------



                          RESONEXT COMMUNICATIONS, INC.

                          By:/s/ David Tahmassebi
                          ----------------------------------------------
                          Name: David Tahmassebi
                          ----------------------------------------------
                          Title: President and CEO
                          ----------------------------------------------